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ABSTRACT 
 
 
 The purpose of this study was to determine mechanisms of reassortment of swine 
influenza viruses and determine if certain reassortant gene combinations can drive 
evolution and host adaptation in the context of the triple reassortant internal gene (TRIG) 
cassette. The TRIG contains a unique combination of a human polymerase basic 1 (PB1) 
gene with avian polymerase basic 2 (PB2) and polymerase acidic (PA) genes. The 
remaining internal genes, nucleoprotein (NP), matrix (M), and non-structural (NS) are of 
swine origin. This differs considerably from classical swine lineage viruses which are 
drifted variants of the 1918 pandemic with all swine origin genes. We hypothesized that 
the viruses containing the TRIG cassette reassort more frequently because the polymerase 
gene constellation is more promiscuous in its ability to replicate with novel HA and NA 
genes. Better understanding of these mechanisms that control reassortment can be applied 
to identifying high risk viruses that have an increased ability to reassort and potentially 
zoonotically transmit to humans. 
 
 The segmented nature of influenza viruses provides an opportunity for gene 
segment reassortment in which a virus can exchange segments with another virus. 
Despite the ability to detect these reassortant viruses, there is little understanding of the 
mechanisms that control or drive this process. The first two aims addressed a barrier in 
the influenza field by determining what mechanisms restrict reassortment in particular 
viral genotypes. This can further be applied to predict the likelihood that other viruses 
may reassort or be restricted from reassorting. Based on epidemiologic data not all 
viruses have the same ability to reassort, thus giving some viruses particular advantages 
over others. However, our studies indicated that there are no virologic specific functions 
that restrict reassortment, but there are trends demonstrating that the TRIG cassette is 
more promiscuous than the classical swine viruses. Thus the propensity of the TRIG 
viruses to reassert, as seen in the field, was likely the result of a change in pig farming 
rather than one particular viral function. 
 
 We next assessed the viral fitness of human HA and NA reassortants on both of 
the swine virus backbones. There were no observable differences with the human H3 and 
N2 on either of the swine backbones when compared to the parental swine backbones. 
However, we did see some viral fitness attenuation when the polymerase complex genes 
were reassorted between the TRIG and classical swine viruses, suggesting that viral 
growth efficiency is altered if the polymerase genes and presumable their interactions are 
changed. 
 
 Influenza gene reassortment plays a major role in the evolution of new viruses, 
however, it may also drive these reassortant viruses to evolve more quickly and adapt to a 
new host. The final aim of the study is evaluated the role reassortment plays in driving 
host adaption and influenza evolution. This aim is designed to test a hypothesis derived 
from natural observations in which avian-like Eurasian swine virus HAs phylogenetically 
cluster with increased nucleotide changes in viruses containing the TRIG NS. We 
hypothesized that the TRIG and TRIG NS increase the number of nucleotide mutations in 
 vi 
the HA gene resulting in increased viral diversity leading to more rapid host adaptation as 
observed by viral fitness in vitro. We found that this evolutionary burst was observed 
when the TRIG NS is rescued on the classical swine virus backbone; however it was not 
seen in a wholly TRIG virus. It is likely the introduction of a different gene segment that 
destabilizes the viral genome leading to the observed evolutionary burst rather than the 
inherent properties of the TRIG NS. However, this does raise the concern that 
reassortment can lead to more rapid host adaption through genetic diversity which could 
lead to novel subtypes entering pigs or humans. Of significant concern is that humans are 
immunologically naïve to most influenza subtypes. These revelations could help direct 
the influenza research community to focus on these particular rapidly evolving viruses 
that pose the most significant threat to public and agricultural health. 
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CHAPTER 1.    INTRODUCTION 
 
 
Influenza A Virus Classification 
 
 Influenza viruses are members of the Orthomyxoviridae family and further 
divided into three genera; Influenza A, B, and C. Influenza A viruses are classified based 
on the two surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA).1 
Currently, there are 16 identified HA subtypes and 9 NA subtypes.2-5 Wild aquatic birds 
have been identified as the natural reservoir, however, Influenza A viruses infect 
numerous hosts, including; ducks, shorebirds, gulls, poultry, pigs, horses, seals, mink, 
and humans. Research in host range and restriction has identified species-specific viral 
gene lineages, but these lineages are not absolute and viruses have shown the ability to 
cross species boundaries.6  
 
 
Influenza A Virus Structure and Function 
 
 
Structure and Genome 
 
 The influenza virus is enveloped with a genome consisting of 8 segmented 
negative-sense RNA strands. Negative-sense RNA must be transcribed in order to 
produce cRNA for full length vRNA transcription and mRNA which will be translated 
into protein. The envelope consists of a host derived lipid bilayer surrounding the protein 
capsid embedded with the HA, NA, and matrix 2 proteins (M2).6,7 The viral capsid is 
composed of matrix 1 (M1) protein which surrounds the viral core consisting of the 
ribonucleoprotein (RNP) complex.7 The RNP complex is made up of the polymerase 
proteins, viral RNA (vRNA), and the nucleoprotein (NP).8 In addition to the polymerase 
complex, an alternative open reading frame in some polymerase basic 1 (PB1) proteins, 
encodes a truncated protein named PB1-F2. This truncated protein targets the inner 
mitochondrial membrane and induces apoptosis.9 The final 2 proteins are the non-
structural protein (NS1) and nuclear export protein (NEP) which are encoded by a single 
RNA segment and NS1 is an interferon antagonist while NEP is responsible for 
trafficking viral proteins and RNPs out of the nucleus. 
 
 Additionally, the segmented genome provides an evolutionary advantage for 
influenza viruses. Not only can the viruses evolve through genetic drift, where mutations 
accumulate due to the low fidelity of the viral polymerase, but they can also evolve 
through reassortment. Reassortment occurs when a cell is “super-infected” with two 
viruses and one or more gene segments from one virus are packaged with the remaining 
gene segments from the second virus. This is particularly important when the two viruses 
are genetically diverse and the surface viral glycoproteins are exchanged, leading to 
antigenic shift. Antigenic shifts are the primary modes of pandemic emergence and the 
direct result of reassortment. 
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Surface Glycoproteins 
 
 The two surface glycoproteins, HA and NA, play the crucial roles of receptor 
binding and membrane fusion, along with sialic acid cleavage, respectively. The HA 
protein is the predominant surface protein with roughly four times as many present 
compared to NA.7 
 
 
 Hemagglutinin. The HA protein consists of a homotrimer and is largely regarded 
as the primary host determinant factor due to the preference of avian HAs to bind to α2,3 
terminally linked sialic acids while mammalian viruses preferentially bind to α2,6 linked 
sialic acids.10,11 In addition to binding to sialic acids along the cell surface, HA also 
causes membrane fusion between the viral envelope and the endosomal membrane to 
release the viral RNP in to the cytoplasm. The inactive from of HA (HA0) consists of a 
non-cleaved homotrimer. The HA0 is cleaved by a species specific trypsin-like protease 
into HA1 and HA2 which remain connected by a disulfide bond.6 The cleavage is 
required for HA activation and infectivity. The globular head of the HA molecule 
consists entirely of the HA1 domain and contains the receptor binding site, while the 
stalk domain consists of primary HA2 and a small portion of HA1. The stalk domain 
contains the proteolytic cleavage sequence which exposes the fusion peptide. Under low 
pH conditions, the HA molecule undergoes a significant conformational shift leading to 
membrane fusion.7  
 
 
 Neuraminidase. The second major surface glycoprotein is NA which is 
responsible for viral spread by cleaving terminal sialic acids and consists of a 
homotetramer.6,7 The enzymatic activity of NA provides multiple functions to the 
influenza virus. During viral budding from the infected cell, the HA proteins can bind to 
target sialic acids, so the NA is required to cleave these targets in order to release the new 
virion. Additionally, as new virions bud, their envelope is host derived and contains 
terminal sialic acids. The NA activity can prevent aggregation of virions by cleaving the 
sialic acids present within the viral envelope thus preventing other virions from binding. 
The sialidase activity can also cleave sialic acids present in mucus along the respiratory 
tract, which helps to prevent viral inactivation by host defenses.12 All of these roles help 
to increase intra-host and inter-host infectivity. Cleaving viral receptors in mucus 
increases the virus’ ability to infect cells along the respiratory tract as well as release 
virions during sneezing to increase transmission. Similarly, preventing virion aggregation 
thereby increasing the distance in which the virus can spread through aerosol droplets to a 
new host. 
 
 
Internal Gene Segments 
 
 The 6 internal gene segments encode 8 to 10 proteins including all of the 
polymerase proteins, the nucleoprotein, both matrix proteins (one of which is a 
transmembrane protein), and the non-structural proteins. 
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 Polymerase Complex. The influenza A polymerase complex is a heterotrimer 
consisting of the polymerase basic protein 2 (PB2), polymerase basic protein 1 (PB1), 
and polymerase acidic protein (PA). The polymerase complex is a RNA-dependent RNA 
polymerase held together by the PB1 N-terminal interaction with PA and C-terminal 
interaction with PB2.13 This complex is responsible for both viral transcription and 
replication. To achieve this end, the PB1 protein binds the terminal ends of vRNA, which 
causes an allosteric shift in PB2 allowing recognition and binding of host capped pre-
mRNAs.14 Binding of vRNA by PB1 also activates endonuclease activity of the PA 
protein, which cleaves the 5’ mRNA cap from host pre-mRNAs to use for initiation of 
viral transcription.15,16 Some studies also suggest that the PA subunit contains proteolytic 
activity of coexpressed proteins to decrease excessive accumulation.17 Additionally, the 
PA subunit has been shown to interact with hCLE which is a host gene transcriptional 
activator.18 
 
 Two other proteins are encoded by the frame shifts in the PB1 and PA reading 
frames. These proteins have not been shown to interact with the polymerase complex. 
The first identified was the polymerase basic 1 frame 2 (PB1-F2) protein. The PB1-F2 
has been shown to localize to the inner mitochondrial membrane and when synthetically 
expressed, induces apoptosis.9 It has also been shown to only cause cell death in 
monocytes and not epithelial cells when expressed during an influenza infection. The 
most recently identified protein is termed the PAX. It has been shown to maintain 
endonuclease activity and inhibits host protein expression through host mRNA 
degradation.16 
 
 
 Nucleoprotein. The primary role of nucleoprotein is to encapsulate the vRNA. 
NP is an arginine-rich monomer, which gives it a net positive charge and allows non-
specific interactions with the negatively charged phosphate backbone of the vRNA.19 By 
surrounding the RNA, NP is a key component of vRNA packaging. NP has also been 
shown to interact with both PB1 and PB2.20,21 This interaction is likely one method of 
regulating the switching of the polymerase activity from mRNA synthesis to vRNA 
synthesis.6 
 
 
 Matrix Proteins 1 and 2. The matrix RNA segment encodes two different 
proteins in two open reading frames, each with very distinct functions. The M1 protein is 
a structural protein that forms the viral capsid, found just beneath the viral lipid envelope. 
The M1 protein has two distinct regions, one of which is hydrophobic and inserts itself 
into the lipid membrane/envelope and the other region which interacts with NEP and 
RNPs.22,23 These interactions are the primary methods in which new virions are 
assembled/packaged and the envelope is pinched off as the virion buds.24 
 
 The M2 protein is a tetramer that forms a transmembrane ion-channel in the 
virion.25 This ion-channel allows for acidification of the virion core as the endosome 
becomes a late endosome. This acidification causes the M1 protein to disassemble and 
release the RNP into the cytoplasm in addition to inducing an HA conformational shift to 
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fuse the membranes.26 Due to the expression and export pathway of the M2 protein, it 
also creates a proton channel in the Golgi apparatus, thereby increasing the pH of the 
Golgi and preventing premature HA conformational shifts.27 
 
 
 Non-Structural Proteins. NS1 is a highly expressed non-structural protein which 
is not incorporated into the virion. Instead of having a role in the virion, NS1 is an 
interferon antagonist.7 It accomplishes this through several different pathways. NS1 has 
been shown to bind to double-stranded RNA (dsRNA).28 This interaction can sequester 
dsRNA from detection by IRF-3 which has been shown to induce activation of IFN-α/β, 
which are the primary components of the host innate response to viral infection.29 
Additionally, through its dsRNA binding domain, NS1 has been shown to prevent 
activation of NF-κB which is also a strong inducer of IFN-α/β.30 These studies have also 
demonstrated that without functional NS1, IFN-α/β is not inhibited by influenza virus 
infection. Some additional functions attributed to NS1 include; regulation of vRNA 
synthesis through interactions with the polymerase complex, enhanced translation of viral 
mRNA over host mRNA, blocking the host antiviral response by inhibiting activity of 
oligoadenylate synthetase and protein kinase R, and disruption of cellular signaling 
pathways by interacting with numerous host proteins through the PDZ domain.31 
 
 The NS2 protein is also known as the nuclear export protein (NEP). As mentioned 
previously, several studies have shown that NEP interacts with the M1 protein which also 
interacts with the RNP complexes.22,32 These interactions occur in the nucleus as new 
vRNA is synthesized and needs to be exported to the cell surface in order to be packaged 
with newly budding virions. To export the newly synthesized RNPs, NEP binds to the 
M1 protein associated with the RNPs and further interacts with human chromosome 
region maintenance 1 protein (CRM1).33 Human CRM1 is a highly conserved nuclear 
export receptor that mediates export of substrates containing a nuclear export signal from 
the nucleus.34 Without the expression of NEP, RNPs localized in the nucleus and did not 
produce any viable virus.33 
 
 
Influenza Virus Lifecycle 
 
 As the virus enters a naïve host, the cleaved HA binds to terminal sialic acids on 
the cell surface. After binding, the virion is endocystosed and as the endosome acidifies, 
the HA complex undergoes a conformational shift in which the hydrophobic fusion 
peptide of HA2 inserts itself into the endosomal membrane. After the fusion peptide is 
inserted, the HA contracts pulling the viral envelope and endosomal membrane together 
resulting in membrane fusion. Additionally, as the late endosome becomes more acidic, 
some of the ions enter the virion through the M2 protein ion channel. When the virion 
reaches a certain pH, the M1 protein begins to disassemble. This process is coordinated 
with the membrane fusion in order to release the viral RNP complexes into the host cell 
cytoplasm as illustrated in Figure 1-1.35 
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Figure 1-1: Illustration of influenza A lifecycle 
Reprinted with permission and under the terms of the Creative Commons Attribution 
Non-Commercial License. Squires, B. et al. BioHealthBase: informatics support in the 
elucidation of influenza virus host pathogen interactions and virulence. Nucleic Acids Res 
36, D497-503, doi:10.1093/nar/gkm905 (2008).  
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 The viral RNP complexes are trafficked into the nucleus where the vRNA 
segments are transcribed into mRNA by the polymerase complex. These newly 
synthesized viral mRNAs are encapsidated by available NP and exported out of the 
nucleus where it is then translated into protein by the host ribosome. It is believed that 
increased concentrations of NP within the nucleus drives a shift from viral mRNA 
transcription to cRNA and vRNA synthesis.6 As vRNA is transcribed, the viral proteins 
are also being synthesized with HA, NA, and M2 being processed and exported through 
the Golgi apparatus to lipid rafts within the host cell membrane. 
 
 As the viral surface glycoproteins and M2 accumulate in lipid rafts, NEP exports 
M1 which is bound to RNPs. These complexes are then trafficked to the cell membrane 
where the M1 then interacts with the cytoplasmic tails of HA and NA. Studies suggest 
that the M1 protein assembles into a capsid structure at the host cell membrane causing 
the new virion to bud from the cell as NA cleaves surface sialic acids.6 
 
 
Influenza A Virus Ecology 
 
 The natural reservoirs for all influenza A virus subtypes are migratory waterfowl, 
however, a relatively large number of hosts, including; ducks, shorebirds, poultry, pigs, 
horses, seals, mink, and humans are susceptible to influenza A virus infection.6 Despite 
its ability to infect such a large host range, influenza A viruses are mainly restricted to 
either avian or mammalian species, primarily mediated through receptor specificity of 
HA.10,11 But, this restriction is far from absolute. Not only can some viruses cross species 
barriers, but when avian viruses jump into mammalian species, primarily pigs, they 
undergo increased nucleotide substitution rates when compared to viruses which have not 
crossed the species barrier.36 In addition to more rapid evolution, the entry of novel 
viruses in a new host increases the possibility for reassortment with native viral 
populations creating the opportunity to develop novel viral strains with pandemic 
potential.37  
 
 Over the past century, humans have been infected with relatively few influenza 
subtypes, primarily H1N1, H2N2, H3N2, and influenza B. The first human subtype 
identified was the H1N1 subtype which emerged as a pandemic strain in 1918. This strain 
was initially believed to be a wholly avian virus that evolved the ability to transmit within 
mammalian species. However, recent phylogenetic analysis has revealed that the 1918 
H1N1 pandemic virus was likely the result of reassortment between different mammalian 
viruses.38,39  It was also determined that the HA segment showed mammalian adapted 
mutations which had diverged from avian strains, suggesting the virus had circulated in 
humans or swine for several years prior to the emergence of the pandemic.40 During the 
pandemic, influenza-like-illness (ILI) was observed in U.S. swine herds indicating that 
the virus had either transmitted to swine from humans or vice versa.41 
 
 Following the 1918 pandemic, the H1N1 subtype remained relatively stable in pig 
populations but showed some genetic drift in the human population. Then, in 1957 the 
H2N2 pandemic virus emerged. This virus displaced the human H1N1 subtype and is 
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believed to be generated by reassortment between the human H1N1 virus which acquired 
Eurasian avian lineage H2, N2, and PB1 gene segments.39,42-44 Phylogenetic analysis also 
suggests that the avian PB1 and N2 segments had entered the mammalian virus 
population several years prior to acquiring the H2 segment. Presumably, the H1N1, 
H1N2, and H2N2 viruses co-circulated until the H2 had adequate time to adapt to 
mammalian host receptors. Unlike the 1918 H1N1 virus, the 1957 H2N2 virus did not 
appear to transmit to swine herds. 
 
 Eleven years after the H2N2 pandemic, a novel H3N2 virus emerged as the 1968 
“Hong Kong Flu” pandemic strain. Phylogenetic data indicated that the circulating H2N2 
virus acquired a novel H3 gene segment and that the two viruses may have co-circulated 
for about 2 years prior to the widespread transmission of the pandemic strain and 
disappearance of the H2N2 virus.39,45 Due to poor swine surveillance at the time, it is 
difficult to determine if the reassortment of these two viruses occurred in swine or 
humans, however, the potential for avian and mammalian virus transmission within the 
swine host cannot be ignored. As with the H1N1 subtype, the H3N2 virus established a 
stable viral lineage within the swine population and the virus was antigenically similar to 
the human pandemic strain. However, the prevalence of the H3N2 subtype was 
significantly lower than that of the classical swine H1N1 lineage.46 Despite the low level 
circulation of H3N2 viruses in swine, the surveillance and phylogenetic information 
described above indicates cross species transmission of both mammalian and avian 
influenza viruses in swine populations providing an ideal host for reassortment to 
continue to occur. 
 
 In 1977 the H1N1 genotype virus was isolated from human in China and shortly 
after in Russia. This H1N1 virus was widespread throughout the Northern Hemisphere by 
1978; however, most of the human population over 20 years of age had been exposed to 
H1N1 genotype virus, so the virus was limited in its ability to infect preventing a new 
pandemic. Due to the high genetic homology to H1N1 viruses from 1950, the H1N1 virus 
isolated in 1977 was likely the result of a laboratory release.47 
 
 In 2009, more than 40 years following the H3N2 pandemic, a novel H1N1 
pandemic virus emerged. Based on surveillance and sequencing data, this virus has been 
determined to potentially be the result of multiple reassortment events. The first 
reassortment likely occurred around 1998 in a swine herd located in North Carolina and 
the resulting virus circulated to swine herds in Minnesota, Iowa, and Texas. This triple 
reassortant virus caused severe ILI in these pig herds. The isolated viruses from these 
herds were identified as reassorted H3N2 viruses with HA, NA, and PB1 of human 
lineage, NS, NP, and M segments of swine lineage, and PB2 and PA of avian lineage.48,49 
This gene clustering of three distinct viral lineages, with avian lineage PB2 and PA 
segments, a human lineage PB1 segment, and swine lineage NP, M, and NS gene 
segments, is known as the triple reassortant internal gene (TRIG) cassette Table 1-1. 
These TRIG containing H3N2 swine viruses further reassorted with H1N1 viruses by 
accepting the HA and NA forming two additional distinct subtypes, H1N1 and H1N2.50 
Finally, one of the swine viruses reassorted with a Eurasian swine virus and acquired the 
Eurasian swine M and NA genes which had not been previously identified outside of  
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Table 1-1: Gene lineage of the TRIG cassette 
 
 TRIG cassette  
 Gene segment Lineage  
 PB2 Avian origin  
 PB1 Human origin  
 PA Avian origin  
 NP Swine origin  
 M Swine origin  
 NS Swine origin  
 
 
Eurasian swine herds.51 This novel H1N1 virus quickly transmitted among the human 
population and completely displaced the previously circulating seasonal H1N1 virus. 
Subsequently, this TRIG containing virus has been isolated from swine and appears to 
continue to reassort. 
 
 
Influenza A in Swine 
 
 Swine are an important host for the maintenance and evolution of influenza 
viruses. The emergence and generation of the 2009 H1N1 pandemic virus has been linked 
to swine, which have been called a “mixing vessel” for influenza viruses. This is 
primarily because the swine respiratory tract contains both the avian influenza virus 
receptor α2,3-linked sialic acids and  the mammalian influenza virus receptor α2,6-linked 
sialic acids. It has also been shown experimentally, that swine can be infected with avian 
influenza viruses.52,53 
 
 
Classical Swine Viruses 
 
 Around the time of the 1918 pandemic, the H1N1 virus entered the U.S. swine 
population and circulated for roughly 80 years with little antigenic or genetic variation.54 
In 1978 a study was completed to determine the prevalence of influenza A viruses within 
U.S. swine herds. The study identified a relatively high prevalence of influenza in swine, 
about 25% of all swine and up to 47% of particular herds, had been exposed or infected 
with the classical swine H1N1 virus which was genetically distinct from the circulating 
human H1N1 genotype.46 However, only about 1.4% of the pigs tested had been exposed 
to influenza of the H3N2 genotype. H3N2 isolated from swine from 1976-1977 were also 
genetically similar to 1975 human isolates, which suggests that they were recent reverse 
zoonotic events of the H3N2 viruses rather than sustained in the swine population like the 
H1N1 viruses.46 Interestingly, H3N2 viruses were frequently isolated from swine in 
Europe and Asia, indicating that the subtype was capable of sustained pig-to-pig 
transmission.55 Surprisingly, over 10 years later in 1988/1989, up to 51% of swine herds 
in the U.S. were identified as seropositive to H1N1 viruses while only 1.1% had been 
exposed or infected by H3N2 viruses.56,57 These surveillance studies illustrate that prior 
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to the 1990s the classical swine H1N1 viruses predominated over any other subtype and 
the only other influenza viruses that could be identified in swine were human origin 
H3N2 subtypes. Despite the low prevalence and few H3N2 swine isolates, the cross 
species transmission provided opportunities for reassortment to occur between human 
adapted viral strains with the circulating swine influenza viruses. 
 
 Swine influenza viruses in the U.S. dramatically changed in the mid to late 1990s. 
From 1997-1998, 7.6% of U.S. pigs tested seropositive against avian H1N1 viruses and 
8% were seropositive against human H3N2 viruses.58 In August of 1998, there was a 
severe outbreak of ILI in swine from North Carolina and subsequent outbreaks on farms 
in Minnesota, Iowa, and Texas.48 Swine H3N2 viruses were later isolated in Nebraska, 
Colorado, Oklahoma, Wisconsin, and Illinois.49 This outbreak was unique not only that it 
was caused by an H3N2 virus, but also it showed increased virulence not previously seen 
with classical H1N1 infections. Not only was this a significant increase in swine H3N2 
infections, but sequencing analysis of the viruses revealed 3 unique genotypes indicating 
that several reassortment events may have occurred. The initial genotype was recovered 
from a pig in Ontario and consisted of a wholly human H3N2 virus that appeared to cross 
the species barrier but unable to transmit to other pigs.57 The second genotype identified 
was a double reassortant virus and contained classical swine PB2, PA, NP, M, and NS 
genes with human PB1, HA, and NA genes.48 The third genotype was a triple reassortant 
virus with classical swine NP, M, and NS genes, human origin PB1, HA, and NA genes 
and avian origin PB2 and PA genes.49 This triple reassortant virus contained and 
propagated the TRIG cassette among swine herds in the U.S. and established several new 
genotypes within the swine population as seen in Table1-2. A large surveillance study 
found that from 1998-2001, out of 3,561 swine samples, 31.7% were influenza positive 
among which 77.3% were H1 positive and 22.7% were H3 positive.59 Further 
characterization revealed that 67.1%, 4.6%, and 26.9% were positive for H1N1, H1N2, 
and H3N2 subtypes, respectively and 1.5% contained H1N1 and H3N2 co-infections.59 
Subsequent swine influenza virus surveillance has shown that H1N1 TRIG viruses have 
completely displaced the classical swine H1N1 viruses across the U.S. Therefore, these 
TRIG containing viruses have a growth advantage over the other genotypes and also can 
be maintained within swine herds rather than continued reverse zoonotic events.57 It is 
evident that the presence of the TRIG cassette helped the virus sustain transmission 
among the swine herds by potentially limiting host restriction through new combinations 
of internal genes, or by increasing the reassortment and evolutionary rate, thereby having 
a superior gene constellation that allowed it to outcompete the other predominant strains. 
 
 
TRIG Cassette 
 
 Following the introduction of the TRIG cassette in the circulating swine viruses, 
additional reassorted viruses discovered were derived from the triple reassortant H3N2 
viruses previously mentioned. They contained novel HA and NA genes on the TRIG 
backbone. In 1999, an H1N2 virus was isolated from an Indiana farm with a classical 
swine H1 and the remaining 7 genes showed sequence homology with the triple 
reassortant H3N2 virus, suggesting this was an additional reassortment after the 
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Table 1-2: Swine virus gene diversity since 1998 
 
Gene 
segment 
csH1N1 
(67.1%) drH1N1 
H3N2 
(26.9%) 
H1N2 
(4.6%) hH1N1 trH1N2 rhH1N1 
PB2 swine avian avian avian human avian avian 
PB1 swine human human human human human human 
PA swine avian avian avian human avian avian 
HA swine swine human swine human human human 
NP swine swine swine swine human swine swine 
NA swine swine human human human human human 
M swine swine swine swine human swine swine 
NS swine swine swine swine human swine swine 
 
The orange boxes represent gene segments of swine origin. The green boxes show gene 
segments of avian origin. The blue boxes indicate human lineage gene segments. The 
pink boxes highlight the H3 or N2 gene segments of human origin while the gray boxes 
indicate the human H1 or N1 gene segments. 
This table was compiled from U.S. swine surveillance studies conducted from 1998 to 
2001. 
 
 
generation of the TRIG cassette (Table 1-2).60 Additionally, in 2004, an H3N1 virus was 
isolated from swine in Minnesota with the same TRIG cassette.61 
 
 Influenza viruses circulating in swine herds experience little selective pressure 
due to the lack of immunity resulting from the short life span of commercial swine, which 
is usually only 5 to 6 months.62 Therefore, it is expected that the influenza virus HA 
nucleotide substitution rate would be relatively low compared to viruses in the human 
population. This was observed up to about 1998; however, with the development of the 
TRIG cassette in swine viruses, the rate of antigenic drift as well as shift, or reassortment, 
has dramatically increased in the past 10-15 years.63 Specifically, the HA of classical 
swine H1N1 from 1930 genetically clusters with more modern classical swine viruses of 
1973 despite some genetic drift and also show considerable serologic cross-reactivity. 
However, the modern H1 reassortant viruses show distinctly clustered HA sequences and 
decreased serologic cross-reactivity with each other and with classical swine HAs when 
tested in hemagglutination inhibition assays.50,64 These studies suggest that there has been 
considerable drift in swine influenza viruses during the last decade when compared to 
classical swine viruses that circulated for roughly 80 years and underwent very little 
antigenic drift. Similar data has been reported about the H3N2 triple reassortant viruses 
circulating in U.S. swine, yet further surveillance needs to be conducted.64  
 
 The reasons for the increased antigenic shift and drift remain largely unclear. 
However, there have been several hypotheses, none of which have been thoroughly 
explored. First, the TRIG cassette, particularly the combination of human and avian 
polymerase genes, is more promiscuous in accepting multiple HAs and NAs. This idea 
has clearly been observed in nature and in the laboratory; however, the actual mechanism 
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is not defined.65 Secondly, viruses containing the TRIG cassette have a significant growth 
advantage over other viruses within swine. This growth advantage not only allowed the 
TRIG virus to outcompete the other circulating strains, but also leads to greater genetic 
diversity providing greater opportunities to either evade host immune responses or for 
generating host adapted mutations. 50 It has been proposed that in addition to having a 
greater growth advantage, the TRIG NS gene is more effective at suppressing the initial 
host interferon response, therefore allowing a more rapid viral replication after infection 
(P. Thomas, personal communication, October 13, 2010). This early rapid viral 
replication increases the possibility of mutant viruses emerging and establishing a new 
viral subpopulation. This would be observed as an increase in the number of mutants or 
the evolutionary rate for TRIG viruses. 
 
 The stable circulation of the classical swine H1N1 viruses indicated that it lacked 
the ability to successfully reassort despite some low level human H3N2 introduction into 
swine. However, after the formation of the TRIG cassette in the mid-1990s, the viral 
diversity in swine had significantly increased by 2002. This swine surveillance data 
clearly demonstrates a clear advantage of reassortment for viruses that contain the TRIG 
cassette when compared to classical swine viruses in the field. This phenomenon was 
further demonstrated in the laboratory by coinfecting Madin Darby canine kidney 
(MDCK) cells with A/TX/6/1996 (TX/96), a human H3N2 virus similar to H3N2 viruses 
isolated from swine in the late 1990s and either A/swine/MN/37866/1999 (MN/99), a 
classical swine H1N1 virus, or A/swine/NC/18161/2002 (NC/02), a triple reassortant 
swine H1N1 virus that contains the TRIG cassette. Analysis of these samples by reverse 
transcription polymerase chain reaction (RT-PCR) revealed that in samples coinfected 
with MN/99 and TX/96, 48 samples were positive for the human H3 gene and of the 48, 
none were positive for MN/99 PA or PB2 genes.66 Contrastingly, the RT-PCR results of 
samples coinfected with NC/02 and TX/96 that of the 38 samples positive for the human 
H3 gene, 28.9% contained the NC/02 PA gene and 52.6% contained both of the NC/02 
PB2 and PA genes.66 
 
 This experiment demonstrated that MN/99 lacks the ability to successfully acquire 
the human H3 gene and produce viable virus. It also supports the surveillance data of 
swine influenza viruses prior to 1998. However, the NC/02 triple reassortant virus 
showed an increased propensity to acquire the human H3 gene under multiple conditions, 
similar to what was observed with swine viruses once the TRIG cassette was introduced 
in the viral population around 1998. 
 
 
Research Aims 
 
 In the last 10-15 years, swine influenza viruses in the U.S. have proven to be 
rapidly evolving through genetic drift and shift compared to what was seen in the 
previous 80 years. This increased genetic drift and shift corresponds with the formation 
of the TRIG cassette in U.S. swine. However, there is little laboratory evidence for why 
the TRIG is not only more promiscuous in its ability to replicate and transmit with novel 
HA and NA gene segments, but also what virologic factors contribute to observed 
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increased nucleotide substitutions. These observations helped to formulate the following 
3 hypotheses. 
 
 
Hypothesis 1 
 
 Viruses including influenza virus have shown the ability to prevent additional 
viruses from infecting the same cell. The classical swine influenza viruses have the 
ability to more effectively exclude a second virus from infecting the same cell when 
compared to the swine viruses which contain the TRIG cassette. 
 
 
Hypothesis 2 
 
 TRIG containing viruses have shown an increased propensity to grow with a 
variety of HA and NA combinations compared to what was seen with classical swine 
viruses. Therefore, the TRIG viruses must reassort more readily and following 
reassortment produce progeny virions with sufficient growth advantages to compete with 
the parental genotypes and transmit to naïve hosts. 
 
 
Hypothesis 3 
 
 Phylogenetic analysis of influenza viruses in nature with the TRIG and with the 
TRIG NS have shown increased nucleotide substitutions in the HA, suggesting they 
evolve more rapidly. If this is a purely virologic aspect, then viruses rescued on the TRIG 
backbone or with the TRIG NS should show increased nucleotide substitutions in rescued 
viruses.  
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CHAPTER 2.    INFLUENZA VIRUS SUPERINFECTION EXCLUSION AND 
GROWTH KINETICS OF REASSORTANTS 
 
 
Introduction 
 
 Reassortment plays a crucial role for influenza virus adaptation and evolution. 
However, the mechanisms that govern reassortment are poorly understood. This includes 
the ability to accept new genes as well as the frequency in which new gene combinations 
arise. The classical swine H1N1 viruses remained genotypically stable for about 80 years. 
However, once the TRIG cassette was formed and propagated within the swine viral 
population, the rate of reassortment greatly increased. Suggesting there is some inherent 
property of the TRIG gene arrangement that allows it to more readily acquire new HA 
and NA genes when compared to the classical swine gene constellations. 
 
 In order for reassortment to occur, a single cell must be infected with at least two 
viruses, also known as superinfection. The NA of influenza viruses may play a role in 
preventing superinfection by cleaving sialic acid receptors off the cell surface as it is 
expressed.67 Plasmid expression of NA in cells resulted in the release of sialic acids from 
the cell surface, prevented HA mediated viral entry, and in the presence of NA inhibitors 
more cells were superinfected with H1 and H3 viral subtypes.  This viral exclusion also 
prevents reinfection of the cell by new budding virions. Other viruses have also been 
shown to possess unique mechanisms to prevent superinfection by reducing expression of 
the viral receptors or inducing internalization of viral receptors.68,69  
 
 Previous experiments have shown that NC/02 is able to reassort with the human 
H3N2 virus, TX/96, while the classical swine MN/99 lacks the ability to reassort. 
Therefore, it is hypothesized that the MN/99 virus is able to more efficiently exclude 
another virus from superinfection compared to NC/02. This would greatly reduce the 
possibility of the MN/99 virus producing reassortant progeny. This will be tested using 
fluorescently labeled monoclonal antibodies specific for H1 or H3 to quantify the number 
of superinfected cells during simultaneous or delayed infections. 
 
 Not only do cells have to be superinfected in order for reassortment to be a 
possibility, but the progeny virions must be of sufficient fitness to compete with or 
outcompete the parental strains. This led the hypothesis that if superinfection exclusion is 
not responsible for the differences between MN/99 and NC/02 in their ability to reassort, 
then the 80 years of MN/99 evolution created an optimized and stable gene constellation 
in which reassorting with human virus gene segments does not produce progeny with the 
growth properties required to outcompete the parental strains. Growth kinetics will be 
completed for these viruses including reverse genetic reassortants to determine if the 
addition of the human HA and NA on the swine backbones causes any attenuation. 
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Materials and Methods 
 
 
Viruses 
 
 For flow cytometry two reverse genetics (RG) viruses RG-MN/99, a classical 
swine H1N1 virus with all 8 gene segments of swine origin lineage, and RG-NC/02, a 
triple reassortant H1N1 virus with the TRIG cassette and swine origin HA and NA genes, 
and one wild type virus TX/96, a human seasonal H3N2 virus with all 8 gene segments of 
human lineage origins, were used for the following experiments. The RG viruses were 
generated using the dual promoter eight plasmid system as outlined in Figure 2-1.70 
Briefly, the RNA is extracted from the virus of interest and is amplified by RT-PCR. The 
amplified gene segments are purified, digested with BsmBI, BsaI, or AarI and then 
ligated into the pHW2000 plasmid. All 8 plasmids are then simultaneously transfected 
into a 90-95% confluent MDCK-293T cell co-culture using TransIT-LT1 (Mirus catalog 
number MIR 2304). The rescued virus supernatants are then injected into 10 day old 
embryonated chicken eggs and incubated at 35°C for 48 hours. The allantoic fluid is 
harvested and re-injected into embryonated chicken eggs for a second passage. The virus 
is harvested, aliquoted, and stored at -80°C. Each vial is only thawed once before use in 
each experiment. 
 
 For the growth kinetics experiments reverse genetics viruses were rescued by 
adding the human H3N2 viral glycoproteins on both of the swine backbones (Table 2-1). 
The MN/TX genotype consists of the human H3 and N2 from TX/96 with the remaining 
6 gene segments from the MN/99 virus. The NC/TX virus contains the TRIG cassette 
with the human H3 and N2 derived from TX/96. 
 
 
Coinfection 
 
 MDCK cells were grown to about 80-90% confluency in a 24-well tissue culture 
plate. Prior to infection, one well was trypsinized and cells were counted using the 
Invitrogen Countess (catalog number C10227). Cells were infected at multiplicities of 
infection (MOI) of 0.01 and 1, based on the live cell counts as outlined. For simultaneous 
infection times, the desired amounts of NC/02+TX/96 and MN/99+TX/96 were mixed 
prior to addition to the cells. For delayed infections, each virus, NC/02, TX/96, or MN/99 
were added at time point 0. These infections were incubated at 37°C with 5% CO2 for 1 
hour and then the viral dilutions were washed from the cells using sterile PBS (pH 7.4). 
Following the wash, infection media (1X minimum essential media (MEM) 
supplemented with antibiotics (Gibco catalog number 15240-062), vitamins (Gibco 
catalog number 11120-052), 400 µM glutamine (Gibco catalog number 25030-081), 
0.1% BSA (Sigma catalog number A8412), and 0.5 µg/ml TPCK-Trypsin) was added and 
incubated at 37°C with 5% CO2 for 24 hours. At 24 hours post infection (hpi), 
supernatants were aspirated from the cells and for single and simultaneously infected 
cells, new infection media was added. For the 24 hour delayed infections, the infection 
media contained the second virus to be added at the proper MOI dilution and plates were  
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Figure 2-1: Illustration of the dual promoter eight plasmid system to rescue 
cloned viruses 
A) Viral RNA is extracted, reverse transcribed, and then amplified using RT-PCR. All 8 
of the amplified dsDNA influenza segments are digested using BsmBI, BsaI, or AarI, and 
ligated into the plasmid pHW2000 directly between the human Pol I promoter and pol I 
terminator, both of which are flanked by the CMV promoter and the BGH 
polyadenylation signal. B) The cloned influenza gene segments in the pHW2000 
expression vector are transfected into confluent MDCK and 293T cell monolayers and 
incubated at 37°C with 5% CO2 for 72 hours. The 293T cells produce the initial virions 
which can infect and replicate in the MDCK cells. 
Reprinted with permission by the National Academy of Sciences, U.S.A. and Dr. Robert 
Webster. Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G. & Webster, R. G. A 
DNA transfection system for generation of influenza A virus from eight plasmids. Proc 
Natl Acad Sci U S A 97, 6108-6113, doi:10.1073/pnas.100133697 (2000). Copyright 
2000 National Academy of Sciences, U.S.A. 
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Table 2-1: Rescued virus gene compositions 
 
 Gene segment source 
RG-virus 
abbreviation PB2 PB1 PA HA NP NA M NS 
NC/02 NC/02 NC/02 NC/02 NC/02 NC/02 NC/02 NC/02 NC/02 
MN/99 MN/99 MN/99 MN/99 MN/99 MN/99 MN/99 MN/99 MN/99 
TX/96* Wild Type 
NC/TX 6+2 NC/02 NC/02 NC/02 TX/96 NC/02 TX/96 NC/02 NC/02 
MN/TX 6+2 MN/99 MN/99 MN/99 TX/96 MN/99 TX/96 MN/99 MN/99 
 
The orange boxes indicate gene segments from the TRIG swine virus NC/02. The blue 
boxes indicate gene segments of classical swine lineage from MN/99 and the green boxes 
are genes derived from the human H3N2 virus, TX/96. 
* TX/96 is a wild type virus and only HA and NA were cloned for rescue on the swine 
viral backbones. 
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incubated at 37°C with 5% CO2 for 1 hour followed by aspiration of the virus supernatant 
and addition of fresh infection media. 
 
 
Antibody Purification and Fluorescent Labeling 
 
 Anti-H1 and anti-H3 antibodies were identified using hemagglutination inhibition 
assays that specifically targeted the NC/02, MN/99, and TX/96 viruses and to confirm 
these antibodies did not non-specifically bind to the alternate subtype. The antibodies 
were purified from the ascites fluid as outlined in Appendix A. Briefly, the lipid content 
is removed from the ascites fluid using PHM-L Liposorb (EMD Millipore catalog 
number 524371) and the monoclonal antibody is bound by a 1 ml HiTrap Protein G 
column (GE Healthcare catalog number 17-0404-01). The column is washed with PBS 
until the flow through contains no detectable protein contamination as determined by 
absorbance reading at 280 nm (A280) less than 0.002 as determined by a NanoDrop 1000 
spectrophotometer instrument. Then the antibody is eluted using an acid buffer into 1 ml 
fractions and only fractions containing protein as determined by A280 readings are 
pooled and desalted using a Zeba spin 7K MWCO, 2 ml spin desalting column (catalog 
number 89889). The final concentration of the IgG was determined by a NanoDrop 1000 
instrument and directly labeled.  
 
 The purified anti-H1 and anti-H3 antibodies were fluorescently labeled with 
Alexa Fluor 488 (Invitrogen catalog number A20181) and Alexa Fluor 555 (Invitrogen 
catalog number A20187), respectively. The antibodies were diluted to 1 mg/ml in 1 ml 
and added 100 µl of 1 M sodium bicarbonate. To the provided reactive dye vial, 100 µl of 
the antibody dilution was added. This was gently inverted on a rocking plate for 1 hour at 
room temperature. This solution was then added to a prepared ~1.5 ml purification resin 
column and centrifuged at 1100 x g for 5 min. The eluent is labeled antibody in 1X PBS 
at a pH of 7.2 with 2 mM sodium azide. 
 
 
Flow Cytometry 
 
 The infected MDCK monolayer was washed with PBS and trypsinized and moved 
to a 96 well plate. The cells were stained with either Alexa Fluor 488 conjugated anti-H1 
antibody or Alexa Fluor 555 conjugated anti-H3 antibody or both. The stained samples 
were analyzed on a BD FACS Canto II. 
 
 
Growth Kinetics 
 
 To an 80% confluent monolayer of MDCK cells, the RG viruses and wt TX/96, as 
outlined in Table 2-1, were used to infect at MOIs of 0.01. MOIs were calculated by 
counting trypsinized cells using the Countess cell counter (Invitrogen catalog number 
C10227). The viruses were diluted in infection media to the appropriate MOI and added 
to the cell monolayers and incubated at 37°C with 5% CO2 for 1 hour. Cell monolayers 
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were then washed with 1X PBS and infection media was added to the washed cells. For 
the MDCK growth kinetic experiments, 2 x 100 µl samples were collected at the 
following time points, 6, 8, 10, 12, 20, 24, 36, and 48 hpi. All of the samples collected 
were stored at -80°C until viral TCID50 titers could be determined. All TCID50 titers were 
determined using MDCK cells by making 10 fold dilutions of each time point and 
infecting a single well of a 96 well plate with one dilution. Each time point was measured 
in quadruplicate using 0.5% (v/v) turkey red blood cells in PBS. To maintain continuity, 
the samples did not undergo any freeze-thaw cycles prior to titration. Significance was 
calculated using a 2way ANOVA analysis. 
 
 
Results 
 
 
Coinfection Exclusion 
 
 As influenza viruses replicate, HA is expressed on the surface of the infected cell, 
which is incorporated into budding virions. Using fluorescent antibodies targeted to these 
HA molecules allowed us to identify H1 and H3 infected cell and quantify the amount of 
cells that were infected by either NC/02, MN/99, or TX/96 as well as those infected by 
both an H1 and an H3 virus. These experiments were designed to determine if MN/99 is 
more capable of excluding superinfection when compared to NC/02, explaining the lack 
of reassortment observed between MN/99 and TX/96. 
 
 Simultaneous infections at an MOI of 0.01 revealed that nearly 3 times fewer cells 
were coinfected between MN/99 and TX/96 (8.8%) when compared to NC/02 and TX/96 
(26.1%) (Figure 2-2A and B). Nearly half of these cells were infected with the MN/99 or 
NC/02 viruses and very few were infected with the TX/96 virus (Figure 2-3). When the 
TX/96 infection is delayed by 24 hours after the initial infection with MN/99 or NC/02, 
0% to 0.3% of the cells, respectively, stained positive for TX/96 infection while over half 
of the cells were infected with MN/99 (69.7%) and nearly all of the cells were infected 
with NC/02 (92.7%) (Figure 2-2C and D). Similar results were observed when the 
MN/99 or NC/02 swine viruses are delayed 24 hours after the TX/96 infection. The 
percentage of coinfected cells ranged from 0.2% when NC/02 is delayed to 0.3% when 
MN/99 was delayed (Figure 2-2E and F). While few cells were coinfected or infected 
with either MN/99 or NC/02 viruses, more than half of the cells analyzed were infected 
with TX/96 with 67.1% infected with TX/96 when MN/99 was delayed and 59.6% 
infected with TX/96 when NC/02 was delayed (Figure 2-2E and F). Despite a 48 hour 
incubation, no conditions resulted in 100% infection rate (Figure 2-3). 
 
 When the MOI was increased to 1, very similar results were observed for the 
delayed infections but a smaller difference was observed during the simultaneous 
infection. Simultaneous infections with TX/96 and either MN/99 or NC/02 lead to very 
few cells only infected with TX/96, 0.8% vs. 0.2%, respectively (Figure 2-4A and B). At 
the higher MOI, there were about 1.6 times more coinfected cells when NC/02 and TX/96 
were used (37.2%) compared to when MN/99 and TX/96 were used (22.9%)  
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Figure 2-2: Flow cytometry dot plots at an MOI of 0.01 
A) MDCK cells simultaneously infected with MN and TX. B) MDCK cells simultaneously infected with NC and TX. C-D) Cells 
infected with TX and either MN or NC added 24 hpi. E-F) MDCK cells infected with TX and either MN or NC added 24 hpi. 
 20 
 
 
 
Figure 2-3: Percentage of cells infected with either H1, H3, or coinfected with a 
starting MOI of 0.01 
Purple represents the percentage of negative cells. Green bars represent H1 infected while 
blue represent H3 infected cells. Red corresponds with coinfected cells. The largest 
percent of coinfected cells occur only during simultaneous H1N1 and H3N2 infection. 
When either H1N1 or H3N2 virus addition was delayed by 24 hours, there is very few to 
no coinfected cells detected. 
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Figure 2-4: Flow cytometry dot plots at an MOI of 1 
A) MDCK cells simultaneously infected with MN and TX. B) MDCK cells simultaneously infected with NC and TX. C-D) Cells 
infected with TX and either MN or NC added 24 hpi. E-F) MDCK cells infected with TX and either MN or NC added 24 hpi.
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(Figure 2-4A and B and Figure 2-5). Additionally, when TX/96 infection was delayed 
24 hours, very few cells became infected with the H3 virus with only a slight increase of 
coinfected cells at 0.3% for MN/99 and TX/96 and 0.7% for NC/02 and TX/96 (Figure 
2-4C and D). Again, when the H1 viruses were delayed by 24 hours, very few cells were 
coinfected with only 1.7% for MN/99 and TX/96 while only 1.1% for NC/02 and TX/96 
(Figure 2-4E and F). Even at the MOI of 1 and 48 hour incubation, not all of the cells 
were infected (Figure 2-5). 
 
 
Growth Differences in MDCK Cells 
 
 At, a simultaneous infection with an MOI of 0.01 there seemed to be more H3 
virus exclusion observed between MN/99 and TX/96 when compared to NC/02 and 
TX/96 which was not seen at an MOI of 1. However, there were still numerous 
superinfected cells between MN/99 and the TX/96 virus providing opportunities for 
reassortment. Any reassortant viruses need to have sufficient growth properties to 
become successful, so, growth kinetic experiments were completed to determine if 
MN/TX viruses lack the fitness required to outcompete MN/99 compared to NC/02 and 
NC/TX viruses. Initial growth kinetic experiments indicate that MN/99 is significantly 
slower at establishing an infection when compared to NC/02, NC/TX, and TX/96 at 10 
and 12 hpi (Figure 2-6). NC/02 did have increased titers over NC/TX at 10 hpi (P<0.01). 
Interestingly, MN/TX grew to higher titers than MN/99 at 12 hpi (P<0.05). Despite the 
early differences observed, all viruses were at similar titers by 24 hpi and remained 
similar through 72 hpi. 
 
 
Discussion  
 
 
Simultaneous Coinfection Provides the Greatest Possibility for Superinfection 
 
 In order for reassortment to occur, two distinct viruses must be able to superinfect 
the same cell. When the second virus is delayed by at least 24 hours, it is evident that the 
initial infecting virus is able to exclude the second virus from superinfection. This could 
be the result of various mechanisms. However, the data here suggests that either the 
second virus is not able to enter the cell or translation of the second viral proteins is 
inhibited. This is evidenced by the fact that no H1 is present on the cell surface when the 
H1 virus is delayed 24 hours and similarly no H3 is present when the H3 virus is delayed 
by 24 hours. Therefore, the infections must occur relatively close together, at least in 
vitro. There would likely be an increased time frame for 2 different viruses to infect a 
single host and still produce reassortants because the respiratory tract of either a human 
or pig will contain significantly more cells than can be modeled in a cell culture dish. For 
example, it can be expected that although full exclusion is seen after 24 hours, in a 
respiratory tract it is unlikely that a second virus would be fully excluded due to the large 
number of uninfected cells. Despite these restrictions, the only difference observed  
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Figure 2-5: Percentage of cells infected with either H1, H3, or coinfected with a 
starting MOI of 1 
Purple represents the percentage of negative cells. Green bars represent H1 infected while 
blue represent H3 infected cells. Red corresponds with coinfected cells. The largest 
percent of coinfected cells occur only during simultaneous H1N1 and H3N2 infection. 
When either H1N1 or H3N2 virus addition was delayed by 24 hours, there was very few 
to no coinfected cells detected. 
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Figure 2-6: Viral growth kinetics on MDCK cells at an MOI of 0.01 
MN/99 grows at a significantly slower rate compared to NC/02 and TX/96 at 10 and 12 
hpi (P<0.001) and at 10 hpi MN/99 titer is significantly lower than NC/TX (P<0.05). 
MN/TX grew to a significantly higher titer at 12 hpi compared to MN/99 (P<0.05). 
NC/02 grew to significantly higher titers compared to NC/TX only at 10 hpi (P<0.01). 
The asterisks denote time points with significant differences observed with the color 
matching the parental strain of the comparison. 
*** P<0.001 
* P<0.05 
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between the number of coinfected cells of MN/99 with TX/96 and NC/02 with TX/96 
occurred at the lower MOI of 0.01 during the simultaneous infection. In both MOI 
conditions there were more coinfected cells when NC/02 and TX/96 than MN/99 and 
TX/96, but this difference could be explained by the difference in growth kinetics of 
NC/02 and MN/99 rather than exclusion, because MN/99 has shown a kinetic delay in its 
ability to establish an infection. Thus, there would be an overall lower percentage of cells 
infected with MN/99 which reduces the possibility for superinfected cells. Additionally, 
the lower percentage observed between MN/99 and TX/96 still provides a large number 
of superinfected cells capable of producing reassortant viruses. So, the biological 
significance of the reduced superinfection percentage is difficult to determine.  
 
 Interestingly, in both MOI conditions, there are a relatively large number of cells 
not infected in some instances with most percentages above 30%. It is expected that after 
48 hour incubations, all of the cells would be infected especially with an MOI of 1. There 
are several possible explanations for this phenomenon. After infection, the cells enter an 
antiviral state in which IFN-α/β are produced as well as increased expression of RNase L 
and other antiviral proteins. This antiviral state has been known to reduce viral protein 
expression and the ability of viruses to infect cells. However, some cell types, including 
MDCK have relatively weak IFN expression profiles. Another possible explanation for 
the uninfected cells would be the production of defective interfering particles (DI). DI 
particles spontaneously arise during viral replication and are usually the result of a 
genetic deletion in one of the segments which results in a noninfectious virus. The 
segment containing the deletion can be preferentially replicated at a higher frequency due 
to its shorter length and can also be encapsidated in budding virions reducing the 
production of viable virions. These DI particles can also bind to naïve cells and induce an 
antiviral state which may be responsible for preventing viral replication in the uninfected 
cells. 
 
 
Both MN/99 and NC/02 Are Compatible with Human H3 and N2 
 
 Although there is reduced opportunity for MN/99 to reassort compared to NC/02, 
the fact that 8-22% percent of cells are coinfected indicates that there is another 
mechanism that has prevented MN/99 reassortment. Not only do the cells need to be 
superinfected, but any progeny reassortant viruses need to have adequate fitness to 
compete with the parental strains. To test if the swine virus backbones are compatible 
with the human H3 and N2 genes and if the reassortant viruses have sufficient fitness to 
compete with the parental strains, growth kinetics were performed on MDCK cells. The 
MN/99 showed a significant disadvantage compared to the other viruses at the early time 
points but was able to recover by 24 hpi. This pattern was mirrored by the MN/TX virus, 
but the reassortant virus grew slightly faster than the wholly classical swine virus. This 
clearly demonstrates that the classical swine gene segments are compatible with the 
human surface viral glycoproteins. It should be noted that even though the human HA 
and NA are compatible on both swine virus backbones, the TRIG virus has a clear growth 
advantage over the classical swine virus in the context of a cell model system. This 
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doesn’t help to establish why MN/99 didn’t reassort, but it does help to explain why the 
TRIG viruses have displaced the classical swine viruses today. 
 
 Interestingly, the wt TX/96 outgrew all of the tested viruses. Previous studies 
have shown a fitness disadvantage for TX/96 in the swine model suggesting that MDCK 
cells may not be the most accurate model for testing fitness and reassortment studies of 
swine viruses. These results should therefore be confirmed in additional models. 
 
 
Conclusions 
 
 Based on the MDCK model, the classical swine viruses are capable of reassorting 
with the human viruses and obtaining the human HA and NA similar to what had been 
seen with the swine viruses containing the TRIG. The cells infected with the classical 
swine virus do show a decreased percentage of superinfection, however, the biological 
relevance is difficult to determine. Due to fewer superinfected cells, there is a reduced 
possibility for reassortment to occur with the classical swine viruses, regardless, there are 
still numerous opportunities for reassortment. 
 
 Additionally, the MN/TX virus showed increased growth kinetics compared to 
MN at early time points suggesting that the reassortant phenotype would be able to 
outcompete the parental strain. The triple reassortant swine virus also showed increased 
growth fitness compared to the classical swine viruses which helps to explain ultimately 
why they have become the predominant swine virus.  
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CHAPTER 3.    INFLUENZA VIRUS GENE COMPATIBILITY AND 
MECHANISMS OF REASSORTMENT 
 
 
Introduction 
 
 Swine viruses with the TRIG cassette were able to displace the previously 
circulating classical swine viruses because they are more fit than the classical swine virus 
MN/99 and the reassortant classical swine virus MN/TX, as determined by growth 
kinetics studies in vitro described in Chapter 2. Interestingly, the human H3N2 virus, 
TX/96, grew extremely well in the MDCK cells, which is contrary to what has been seen 
in in vivo pig experiments previously.66 This indicates that the results need to be 
confirmed in an alternate model that mirrors epidemiological data. To confirm the 
Chapter 2 results, primary swine respiratory epithelial cells (pSRECs) were cultured to 
better model in vivo growth kinetics.71 
 
 The segmented nature of the influenza genome provides opportunities for 
reassortment to occur because individual segments can be packaged within virions of a 
different influenza virus. Recent studies have shown that reassortant viruses are generated 
quite readily in vitro.72-74 Although the segmented genome increases the possibility for 
the emergence of numerous reassortant viruses, there are multiple mechanisms which 
restrict this ability, many of which have not been thoroughly investigated. This was 
clearly demonstrated in vivo where swine were coinfected with a classical swine H1N1 
and a TRIG H3N2 swine virus. Multiple reassortants were detected in the infected 
animals but only certain viruses were capable of transmission.65 One mechanism of 
restriction is that the HA and NA proteins need to be balanced. If the HA binds too 
tightly compared to NA activity, then the budding virions will not efficiently release. 
These virions will also have an increased tendency to aggregate. Conversely, if the NA is 
relatively more active, then the HA may not have enough binding affinity to bind to the 
cell long enough to be endocytosed, precluding infection.75,76 As mentioned previously, 
HA fusion is a pH dependent process; similarly, M1 oligomerization and disassembly are 
dependent on the pH.77,78 There is no direct evidence, but presumably the HA and M need 
to be pH balanced so that the HA does not fuse the membranes prior to the proper 
acidification of the virion core and disassembly of the matrix capsid and vice versa. 
Additionally, the interactions of the polymerase proteins require that they are compatible 
with each other, capable of recognizing the RNP’s of the particular viral genotype, as 
well as the ability to function within particular cell types.7,79,80  
 
 Clearly, reassortment is limited by multiple polygenic mechanisms. To compare 
the reassortment abilities of the classical swine viruses versus triple reassortant swine 
viruses with a human H3N2 virus, primary swine respiratory epithelial cells (pSRECs) 
were coinfected with A/TX/6/1996 (TX/96) a human H3N2 and either 
A/swine/MN/37866/1999 (MN/99) a classical swine H1N1 virus, or 
A/swine/NC/18161/2002 (NC/02) a triple reassortant swine virus that contains the TRIG 
cassette. To test the natural ability of these viruses to reassort, swine respiratory cells 
were coinfected with TX/96 and MN/99 or NC/02.  
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 To expand upon previous reassortment experiments in which only the presence of 
classical swine or triple reassortant swine PB2 or PA genes with human H3N2 
glycoproteins,66 the following experiments look at reassortment potential of all 8 gene 
segments through the use of deep sequencing. These experiments also explore the growth 
effects of polymerase complex reassortment by using reverse genetics to rescue viruses 
with differing polymerase gene compositions. 
 
 
Materials and Methods 
 
 
Reverse Genetics Viruses 
 
 For the following experiments multiple reverse genetics viruses were rescued 
based around the RG-MN/99 classical swine H1N1 virus, the RG-NC/02 triple 
reassortant H1N1 virus, and TX/96 human H3N2 virus. The RG viruses were generated 
using the dual promoter eight plasmid system as outlined in Figure 2-1 and Chapter 2.70 
The rescued virus supernatants are then injected into 10 day old embryonated chicken 
eggs and incubated at 35°C for 48 hours. The allantoic fluid was harvested and re-
injected into embryonated chicken eggs for a second passage. The virus was harvested, 
aliquoted, and stored at -80°C. Each vial was only thawed once before use in each 
experiment. All of the genotypes used for the growth kinetics experiments are identified 
in Table 3-1. 
 
 
Primary Swine Respiratory Epithelial Cells (pSRECs) 
 
 Due to previous experiments showing MDCK growth kinetics studies differing 
from in vivo observations, it was determined a new model needed to be utilized to more 
accurately model swine. Isolation and growth of the primary swine respiratory epithelial 
cells was adapted from methods developed in the lab of Chris Olsen and outlined in 
Appendix B.71,81 Briefly, pig tracheas were collected courtesy of David Keith at the 
Fayette Packing Company in Eads, TN. The epithelial cells were enzymatically digested 
from the trachea with a Pronase/DNase mixture (56 mg Pronase (Roche catalog number 
165921), 4 mg DNase (sigma catalog number DN-25)).Adherent fibroblasts were 
removed by incubating the cell suspension on uncoated tissue culture treated petri dishes 
(BD Biosciences, Falcon, catalog number 353003). The epithelial cells were collected 
and centrifuged at 1200 RPM for 10 min at 4°C and then resuspended in 100 ml of 
DMEM/F12 media (Invitrogen catalog number 11320-033) prior to counting on a 
Countess cell counter (Invitrogen catalog number C10227). After counting the cells were 
centrifuged again at 1200 RPM for 10 min at 4°C and resuspended in BEGM (Lonza 
catalog number CC-3170) supplemented with 20% FCS to 4x106 cells/ml. On ice, a 
solution of BEGM, 20% FCS and 20% DMSO was added dropwise to the cell suspension 
until the final cell concentration was 2x106 cells/ml. The cell suspension was aliquoted in 
1 ml volumes and stored in the gas phase of a liquid nitrogen storage tank. 
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Table 3-1: Gene segment origins for rescued viruses 
 
 Gene segment source 
RG-virus 
abbreviation PB2 PB1 PA HA NP NA M NS 
NC/02 NC/02 NC/02 NC/02 NC/02 NC/02 NC/02 NC/02 NC/02 
MN/99 MN/99 MN/99 MN/99 MN/99 MN/99 MN/99 MN/99 MN/99 
TX/96* Wild Type 
NC/TX NC/02 NC/02 NC/02 TX/96 NC/02 TX/96 NC/02 NC/02 
MN/TX MN/99 MN/99 MN/99 TX/96 MN/99 TX/96 MN/99 MN/99 
MN/TX/NC-
PB1 MN/99 NC/02 MN/99 TX/96 MN/99 TX/96 MN/99 MN/99 
MN/TX/NC-
PB2 NC/02 MN/99 MN/99 TX/96 MN/99 TX/96 MN/99 MN/99 
MN/TX/NC-
PA MN/99 MN/99 NC/02 TX/96 MN/99 TX/96 MN/99 MN/99 
MN/TX/NC-
PB2 PA NC/02 MN/99 NC/02 TX/96 MN/99 TX/96 MN/99 MN/99 
MN/TX/NC-
Pol NC/02 NC/02 NC/02 TX/96 MN/99 TX/96 MN/99 MN/99 
MN/TX/NC-
NS MN/99 MN/99 MN/99 TX/96 MN/99 TX/96 MN/99 NC/02 
NC/TX/MN-
PB1 NC/02 MN/99 NC/02 TX/96 NC/02 TX/96 NC/02 NC/02 
 
The orange boxes indicate gene segments from the TRIG swine virus NC/02. The blue 
boxes indicate gene segments of classical swine lineage from MN/99 and the green boxes 
are genes derived from the human H3N2 virus, TX/96. 
* TX/96 is a wild type virus and only HA and NA were cloned for rescue on the swine 
viral backbones. 
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 Prior to pSREC propagation, tissue culture flasks or plates were coated with 5% 
(w/v) type VI human placental collagen (Sigma catalog number C7521) dissolved in 
ddH2O with 0.2% (v/v) glacial acetic acid and incubated at room temperature overnight. 
Prior to use, the collagen coating solution was aspirated and the flasks or plates were 
allowed to fully dry in a biosafety cabinet. 
 
 Cell vials were removed from liquid nitrogen storage and thawed in a 37°C water 
bath and the cell suspension was transferred to a 15 ml tube to be slowly resuspended. 
Once fully resuspended in 10 ml of DMEM/F12 or BEGM, the cells were added to a 75 
cm2 tissue culture flask with 15 ml of BEGM and incubated at 37°C with 5% CO2 
overnight. Half of the media was replaced 1 or 2 days after seeding and the cells were 
typically 80-90% confluent 2-4 days later. 
 
 
Coinfections 
 
 To show whether MN/99 and NC/02 are able to reassort with TX/96 at different 
frequencies, pSRECs were coinfected and progeny viruses were genotyped. Six-well 
tissue culture plates were prepared with pSRECs and incubated until  they were 80-90% 
confluent. Once nearly confluent, cells were counted to calculate MOIs. The pSRECs 
were simultaneously infected with TX/96 and either NC/02 or MN/99 each at an MOI of 
0.01. The viral dilution was incubated on the cells at 37°C at 5% CO2 for 1 hour and then 
the cells were washed with PBS. Fresh BEGM, supplemented with 0.5 µg/ml TPCK-
Trypsin, was added and the infected pSRECs were incubated for 48 hours. After 48 hours 
the supernatants were collected and stored at -80°C until plaque purification. 
 
 For plaque purification, three 6-well tissue culture plates per coinfection were 
prepared with MDCK cells in order to pick 96 plaques. For each coinfection, the virus 
was diluted 1 to 1x10-4 in 8 ml of infection media and serially diluted to 1x10-6. To 
ensure only H3 viruses were selected for sequencing, 80 µl of an anti-H1 antibody 
(selected from the St. Jude repository and created against NC/02) was added to each 
dilution for a 1:100 dilution. Each dilution was incubated on ice for 1 hour prior to viral 
absorption. The cells were then washed with 1X PBS and 1 ml of the viral dilution was 
added to each well. The plates were incubated at 37°C with 5% CO2 for 1 hour. The virus 
dilution was then aspirated and the MDCK monolayers were washed with 1X PBS and 
the cells were overlaid with 1X infection media mixed with 0.9% bacto agar (BD 
Biosciences catalog number 214010) and supplemented with 0.5 µg/ml TPCK-Trypsin 
and incubated at 37°C with 5% CO2 for 48 hours. Identifiable isolated plaques were 
aspirated using a wide bore pipet tip (Fisherbrand catalog number 02-707-74). The viral 
plug was then ejected into one well of an 96-well tissue culture plate about 80% 
confluent with MDCK cells and each plate was incubated for an additional 72 hours. To 
confirm viral growth, a hemagglutination assay was performed by adding 25 µl of 1X 
PBS to a 96-well round-bottom plate followed by 25 µl of the viral supernatant and 
finally 50 µl of 0.5% (v/v) turkey red blood cells. The plate was then gently tapped to 
mix and incubated at room temperature for about 30 min. After the incubation, the plates 
were read for red blood cell agglutination. 
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Identification of Reassortants 
 
 To identify and quantify the reassortant viruses, the Illumina MiSeq platform was 
utilized for multiplex full genome sequencing of 96 samples in a single run. The viral 
RNA was extracted using the Ambion MagMAX-96 AI ND Viral RNA Isolation Kit 
(catalog number AM1835). The MagMAX kit is a magnetic bead based system in which 
the virus was lysed and the RNA was bound on magnetic beads. The beads were washed 
to purify the sample of contaminating protein and DNA. Finally, the RNA was eluted off 
of the magnetic beads. The purified viral RNA was reverse transcribed using SuperScript 
III reverse transcriptase (Invitrogen catalog number 18080044)  and the cDNA was 
amplified using Phusion High-Fidelity PCR Master Mix (New England BioLabs catalog 
number M0531L) combined with the primers in Table 3-2 and using the thermocycler 
conditions outlined in Table 3-3. The amplified samples were then fragmented to 400-
500 base pairs using the Covaris E220 Focused-ultrasonicator with samples in AFA 
microtubes (Covaris catalog number 520078) at a 10% duty cycle, intensity of 5, 200 
cycles per burst, for a total of 70 seconds at 4°C. After shearing, the samples were 
processed following the Bioo Scientific NEXTflex DNA sequencing kit (Bioo Scientific 
catalog number 5140-02). This procedure added unique adapters to each sample. The 
samples then underwent size selection, PCR enrichment, and a final magnetic bead clean 
up. The samples were then submitted to the St. Jude Hartwell Center and sequenced on 
the Illumina MiSeq system. The subsequent sequencing data was analyzed using the CLC 
Genomics Workbench version 6 program.  
 
 
Growth Kinetics 
 
 The RG viruses and wt TX/96, as outlined in Table 3-1, were used to infect 
MDCK cell monolayers at an 80-90% confluency or pSRECs at an MOI of 0.01. MOIs 
were calculated by counting trypsinized cells using the Countess (Invitrogen catalog 
number C10227). The viruses were diluted in infection media to an MOI of 0.01 and 
added to the cells. After about an hour the cells were gently washed with 1X PBS and 
infection media with 0.5% TPCK-Trypsin was added. For the MDCK growth kinetic 
experiments, 2 x 100 µl samples were collected at the following time points, 6, 8, 10, 12, 
20, 24, 36, and 48 hpi. All of the samples collected were stored at -80°C until viral 
TCID50 titers could be determined. For the pSREC infections, 2 x 100 µl samples were 
collected at 10, 12, 14, 16, 18, 20, 24, 36, and 48 hpi. These viral samples were also 
stored at -80°C until TCID50 titers could be determined. No samples were thawed prior to 
titration. All TCID50 titers were determined using MDCK cells in a 96 well flat bottom 
tissue culture plate at 80-90% confluency. Significance was calculated using a 2way 
ANOVA analysis. 
 
 
Pig Infections and Transmission 
 
 Twenty-two two-week-old influenza negative pigs were received from 
Northwoods Pork (Parker Prairie, MN). The pigs were divided into four groups of 5 pigs  
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Table 3-2: Primer sequences used for influenza genome amplification 
 
Primer name Primer sequence 
Uni 12 AGCAAAAGCAGG 
Uni 13 AGTAGAAACAAGG 
Ba-PB2-1 TATTGGTCTCAGGGAGCGAAAGCAGGTC 
Ba-PB2-2341R ATATGGTCTCGTATTAGTAGAAACAAGGTCGTTT 
Bm-PB1-1 TATTCGTCTCAGGGAGCGAAAGCAGGCA 
Bm-PB1-2341R ATATCGTCTCGTATTAGTAGAAACAAGGCATTT 
Bm-PA-1 TATTCGTCTCAGGGAGCGAAAGCAGGTAC 
Bm-PA-2233R ATATCGTCTCGTATTAGTAGAAACAAGGTACTT 
 
 
 
 
Table 3-3: Thermocycler conditions for full influenza genome amplification 
 
Temperature Time Cycling repeats 
98°C 30 sec  
98°C 10 sec 
10 45°C 30 sec 
72°C 90 sec 
   
98°C 10 sec 
20 58°C 30 sec 
72°C 90 sec 
72°C 10 min  
4°C Hold  
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and one group of 2 pigs under BSL-2 conditions and each group was housed in straw 
lined pens in individual cubicles with no contact with any other group. All pigs had 
access to food and water ad libitum and social enrichment items were included in each 
pen.  
 
 The viruses, RG-MN/TX, RG-NC/TX, TX/96, RG-MN/TX/NC-PB1, were 
diluted to 1x106 plaque forming units (PFU)/ml in 15 ml of 1X PBS and 1X egg 
antibiotic (2000 units/ml penicillin, 400 units/ml streptomycin, 200 units/ml Polymyxin 
B, 50 µg/ml gentamicin). Two pigs from each group were infected intranasally with 1-
2x106 PFU of one of the listed viruses using a metered pump nasal spray bottle (Health 
Care Logistics catalog number 10271). PBS with egg antibiotic was used for the control 
pigs. The pigs were restrained and 2 pumps of the viral dilution were administered to 
each nostril for a total administration of about 2 ml. Each pig was monitored daily for any 
clinical signs of disease. 
 
 Starting 1 day post infection (dpi) and every-other day until 15 dpi, all pigs were 
swabbed in each nostril and the swabs were placed in 500 µl isolation media aliquots 
(Table 3-4) and held on ice until they could be stored at -80°C. The swabs were then 
titrated on MDCK cells to calculate TCID50 values as described for growth kinetics. 
 
 
Results 
 
 
Reassortment Frequency 
 
 To test the inherent ability of MN/99 and NC/02 to reassort with TX/96, the 
pSRECs were coinfected at an MOI of 0.01 and the progeny were fully genotyped to 
identify and quantify the number of reassortant viruses created. A surprisingly large 
variety of reassortant viruses were recovered from the pSREC coinfections between 
MN/99 and TX/96 (Table 3-5). The most prevalent virus recovered was the wt TX/96 
virus at 14% of the 93 genotyped viruses. Nearly 80% of the viruses had acquired the 
human H3 segment. The MN/99 NP gene segment appeared to reassort the most 
frequently and was identified in about 74% of the viruses followed by NS at 63% and M 
 
 
Table 3-4: Viral isolation media composition 
 
Reagent Volume for 100 ml Final concentration 
PBS 45 ml  
Glycerol 50 ml 50% 
100X Pen-Strep 1 ml Penicillin (1000 u/ml); streptomycin (200 µg/ml 
Nystatin 1 ml 50 u/ml 
Polymyxin B 2 ml 100 u/ml 
Gentamicin 0.5 ml 200 µg/ml 
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Table 3-5: Reassortment frequency between MN/99 and TX/96 when coinfected 
in pSRECs at an MOI of 0.01 
 
PB2 PB1 PA HA NP NA M NS Number identified 
% of 
sample 
TX TX TX TX TX TX TX TX 13 14.0% 
TX TX MN TX MN TX MN MN 10 10.8% 
TX TX TX TX MN TX TX TX 7 7.5% 
TX TX TX TX MN TX MN MN 6 6.5% 
TX TX TX TX MN TX TX MN 6 6.5% 
MN TX MN TX MN TX MN MN 4 4.3% 
MN TX MN MN MN TX MN MN 3 3.2% 
MN TX TX TX MN TX MN MN 3 3.2% 
TX MN MN TX MN TX MN MN 3 3.2% 
TX TX MN MN MN TX MN MN 3 3.2% 
TX TX MN TX MN MN MN MN 3 3.2% 
TX TX MN TX MN TX TX TX 3 3.2% 
TX TX MN TX TX TX TX TX 3 3.2% 
TX TX TX MN MN TX TX MN 2 2.2% 
TX TX TX TX MN MN MN MN 2 2.2% 
TX TX TX TX TX MN TX TX 2 2.2% 
MN MN MN MN MN MN MN MN 1 1.1% 
MN MN MN MN MN TX MN MN 1 1.1% 
MN TX MN MN TX TX MN MN 1 1.1% 
TX MN MN MN MN MN TX MN 1 1.1% 
TX MN MN MN MN TX MN MN 1 1.1% 
TX MN TX TX MN TX MN MN 1 1.1% 
TX TX MN MN MN MN MN MN 1 1.1% 
TX TX MN MN MN MN TX MN 1 1.1% 
TX TX MN MN MN TX TX TX 1 1.1% 
TX TX MN TX MN TX MN TX 1 1.1% 
TX TX MN TX TX MN MN MN 1 1.1% 
TX TX MN TX TX TX MN TX 1 1.1% 
TX TX MN TX TX TX TX MN 1 1.1% 
TX TX TX MN MN MN MN MN 1 1.1% 
TX TX TX MN MN MN TX TX 1 1.1% 
TX TX TX MN TX MN MN MN 1 1.1% 
TX TX TX TX MN MN MN TX 1 1.1% 
TX TX TX TX MN MN TX MN 1 1.1% 
TX TX TX TX MN TX MN TX 1 1.1% 
TX TX TX TX TX TX TX MN 1 1.1% 
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Table 3-5: (Continued) 
 
The blue boxes indicate gene segments of classical swine lineage and the green boxes are 
genes derived from the human H3N2 virus, TX/96. 
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at 54%. Additionally, of the 74 viruses that were identified as H3, 63 (85%) also 
contained the TX/96 PB2 and PB1 gene segments. Only 9.5% of the 74 H3 viruses had 
the MN/99 PB2 gene and only 5.5% had the MN/99 PB1 gene segment. 
 
 Based on correlation analysis of the genotypes identified between MN/99 and 
TX/96, four gene segments were shown to share more than 15% of the variance in 
common (Table 3-6). The M and NP correlated in 19.3% of the genotypes while M and 
PA shared 20% of the variance. The NS segment correlated with both the NP at 27.2% 
and the M segment at 40.9%. 
 
 There was less viral diversity identified in the genotyped viruses collected from 
the NC/02 and TX/96 coinfections. (Table 3-7). There were only 21 different genotypes 
identified compared to the 36 genotypes between MN/99 and TX/96. The most dominant 
genotype identified was the human H3 with the remaining 7 gene segments from NC/02 
(34.4%). The second most prevalent genotype was very similar, with both the H3 and 
TX/96 PB2 gene segment and the other 6 segments were from NC/02 (15.6%). Of the 96 
samples genotyped, 88.5% of them were H3 positive. Only 27 (31.8%) of the 85 H3 
viruses contained the human derived PB1 segment while 58 (68.2%) contained the NC/02 
PB1 segment. The most interesting aspect of these reassortants was that 81 of the 85 
(95.3%) H3 viruses contain at least one polymerase segment from the NC/02 virus. Of 
the 85 H3 viruses 44.7% had all polymerase segments from NC/02. While 21.1% had 
both PB1 and PA from NC/02, only 8.2% had NC/02 PB2 and PA gene segments. Only 1 
virus (1.2%) had both PB2 and PB1 from NC/02. There are considerably more NC/02 
polymerase gene segments reassorted with the human H3 than what was observed 
between MN/99 and TX/96 where only 34 of the 74 (45.9%) H3 viruses contain at least 
one MN/99 segment, most of which is the PA gene segment 23 of 34 (67.6%). 
 
 
Table 3-6: Correlation analysis of MN and TX reassortant genotypes 
 
Gene 
segment PB2 PB1 PA HA NP NA M NS 
PB2  0.098 0.239 0.257 0.167 -0.110 0.374 0.306 
PB1 0.010  0.247 0.225 0.181 0.053 0.208 0.233 
PA 0.057 0.061  0.268 0.214 -0.002 0.447 0.317 
HA 0.066 0.051 0.072  0.177 0.243 0.149 0.274 
NP 0.028 0.033 0.046 0.031  0.025 0.439 0.522 
NA 0.012 0.003 0.000 0.059 0.001  0.104 0.128 
M 0.140 0.043 0.200 0.022 0.193 0.011  0.639 
NS 0.094 0.054 0.100 0.075 0.272 0.016 0.409  
 
The top half of the table shows the correlation r values and the bottom half are the r2 
values which are the coefficient of determination values and represent the fraction of 
variance shared between the gene segments. 
Highlighted values show 15% or more correlation between the gene segments. 
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Table 3-7: Reassortment frequency between NC/02 and TX/96 when coinfected 
in pSRECs at an MOI of 0.01 
 
PB2 PB1 PA HA NP NA M NS Number identified 
% of 
sample 
NC NC NC TX NC NC NC NC 33 34.4% 
TX NC NC TX NC NC NC NC 15 15.6% 
NC NC NC NC NC NC NC NC 9 9.4% 
NC TX NC TX NC NC NC NC 7 7.3% 
TX TX NC TX NC NC NC NC 5 5.2% 
NC NC NC TX NC TX NC NC 4 4.2% 
TX TX TX TX TX TX TX TX 4 4.2% 
TX TX NC TX NC TX NC NC 3 3.1% 
TX NC NC TX NC TX NC NC 2 2.1% 
TX TX TX TX NC NC NC NC 2 2.1% 
TX TX TX TX NC NC TX NC 2 2.1% 
NC NC NC TX NC NC NC TX 1 1.0% 
NC NC TX TX NC NC NC NC 1 1.0% 
NC TX NC NC NC NC NC NC 1 1.0% 
NC TX NC TX NC TX NC NC 1 1.0% 
NC TX TX TX NC TX TX NC 1 1.0% 
NC TX NC TX NC TX NC NC 1 1.0% 
TX NC NC TX NC TX NC TX 1 1.0% 
TX NC TX TX TX TX TX NC 1 1.0% 
TX TX NC NC NC NC NC NC 1 1.0% 
TX TX NC TX NC NC NC TX 1 1.0% 
 
The orange boxes indicate gene segments of the TRIG swine lineage and the green boxes 
are genes derived from the human H3N2 virus, TX/96. 
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 The genotypes identified between NC/02 and TX/96 showed an increased number 
of correlated gene segments when compared to MN/99 and TX/96. The PA segment 
correlated with numerous segments including PB1 (16.3%), NP (42.5%), M (70.2%), and 
NS (16.2%) (Table 3-8). The NP segment also showed significant correlation with the 
NA (23.8%), M (60.4%), and NS (43.0%) segments. The NA and M segments also 
shared 18.9% of the variation while M and NS were correlated in 24.5% of the viruses. 
 
 
MDCK Cell Growth Differences 
 
 Growth kinetics of particular viral reassortants were tested to identify if they have 
sufficient growth fitness to compete with the parental strains. As seen in Figure 3-1, the 
parental viral strains show very similar growth kinetics to the 6+2 viruses where the 
human H3 and N2 are added on either the classical swine or the triple reassortant 
backbones. The different viral surface glycoproteins showed no effect on the viral growth 
kinetics. Compared to MN/99, NC/02 grew to higher titers at 10 and 12 hpi (p<0.001) 
and 20 and 24 hpi (p<0.01), while NC/TX grew to higher titers than MN/TX at 10 and 20 
hpi (p<0.001). Similarly, TX/96 grew to significantly higher titers than MN/TX at 10 and 
12 hpi (p<0.001) and 20 hpi (p<0.01). 
 
 When the gene segments of the polymerase complex in both the classical swine 
virus and TRIG virus are reassorted in the context of the human H3 and N2, there are 
some identifiable growth differences observed (Figures 3-2 and 3-3). The reverse 
genetics MN/TX virus grew at significantly lower titers compared to TX/96 at 10, 12, and 
20 hpi (P<0.001). Additionally, none of the reverse genetics viruses containing any of the 
NC/02 polymerase segments showed increased growth kinetics compared to MN/TX. 
 
 
Table 3-8: Correlation analysis of NC and TX reassortant genotypes 
 
Gene 
segment PB2 PB1 PA HA NP NA M NS 
PB2  0.318 0.320 0.218 0.296 0.223 0.303 0.272 
PB1 0.101  0.404 0.094 0.254 0.265 0.376 0.252 
PA 0.102 0.163  0.129 0.652 0.330 0.838 0.402 
HA 0.047 0.009 0.017  0.084 0.173 0.108 0.101 
NP 0.088 0.065 0.425 0.007  0.488 0.777 0.656 
NA 0.050 0.070 0.109 0.030 0.238  0.435 0.379 
M 0.092 0.142 0.702 0.012 0.604 0.189  0.495 
NS 0.074 0.063 0.162 0.010 0.430 0.143 0.245  
 
The top half of the table shows the correlation r values and the bottom half are the r2 
values which are the coefficient of determination values and represent the fraction of 
variance shared between the gene segments. 
Highlighted values show 15% or more correlation between the gene segments. 
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Figure 3-1: MDCK growth kinetics of parental and 6+2 viruses at an MOI = 0.01 
There were no significant differences observed between MN/99 and MN/TX or between 
NC/02 and NC/TX. MN/99 does show significantly lower titers than both NC/02 and 
TX/96 at 10 and 12 hpi (P<0.001) and just NC/02 at 20 and 24 hpi (P<0.01). MN/99 also 
has significantly lower viral titers at 12 and 20 hpi when compared to NC/TX (P<0.05 
and P<0.01 respectively). The asterisks denote time points with significant differences 
observed with the color matching the parental strain of the comparison. 
*** P<0.001 
** P<0.01 
* P<0.05 
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Figure 3-2: Growth kinetics of RG viruses in MDCK cells where the polymerase 
gene segments have been swapped on the MN/TX viral backbone 
MN/TX grows at a significantly slower rate compared to TX/96 at 10, 12, and 20 hpi 
(P<0.001). When comparing all of the polymerase reassortants to MN/TX, none show 
increased growth kinetics in MDCK cells. Addition of the NC-PB1 resulted in 
significantly lower titers at 12 hpi (P<0.05) and 24 hpi (P<0.001). The NC-PB2 causes a 
slight growth reduction at 12 phi (P<0.05) while NC-PA causes reduced viral titers at 12 
(P<0.05), 24, 36 (P<0.001), and 48 (P<0.01) hpi. When both NC-PB2 and PA are 
included they have a cumulative effect and significantly inhibit attenuate viral growth 
compared to MN/TX at 12 and 20 hpi (P<0.05) and 24-48 (P<0.001) hpi. The asterisks 
denote time points with significant differences observed with the color matching the 
parental strain of the comparison. 
*** P<0.001 
** P<0.01 
* P<0.05 
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Figure 3-3: Growth kinetics of RG viruses in MDCK cells where MN-PB1 was 
swapped on the NC/TX viral backbone 
NC/TX showed no significant growth difference compared to TX/96. Addition of the 
MN-PB1 did attenuate the virus compared to NC/TX at 10, 12, 20, 24, and 48 (P<0.001) 
hpi. Inclusion of the NC PB2 and PA in the MN/TX/NC-PB2 PA virus did not rescue the 
higher growth kinetics seen in the NC/TX virus and was attenuated in all time points 
tested (10-48 hpi P<0.001). The asterisks denote time points with significant differences 
observed with the color matching the parental strain of the comparison. 
*** P<0.001 
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MN/TX/NC-PB1 grew to significantly lower titers at 12 (P<0.05) and 24 hpi (P<0.001). 
The NC-PB2 rescued in the MN/TX virus, causes a slight growth attenuation at 12 hpi 
(P<0.05) while the NC-PA causes reduced viral titers at 12 (P<0.05), 24, 36 (P<0.001), 
and 48 (P<0.01) hpi. When both the PB2 and PA are included in MN/TX/NC-PB2 PA,  
they have a cumulative effect and significantly inhibit attenuate viral growth compared to 
MN/TX at 12 and 20 hpi (P<0.05) and 24-48 (P<0.001) hpi (Figure 3-2). 
 
 NC/TX showed no significant growth difference compared to TX/96. Addition of 
the MN-PB1 did attenuate the virus compared to NC/TX at 10, 12, 20, 24, and 48 
(P<0.001) hpi. Inclusion of the NC PB2 and PA in the MN/TX/NC-PB2 PA virus was 
unable to rescue the higher growth kinetics seen in the NC/TX virus and the virus was 
significantly attenuated in all time points tested, 10-48 hpi (P<0.001) (Figure 3-3).  
 
 Surprisingly, when the TRIG NS was reassorted with the MN/TX, growth was 
slowed at 12, 20, and 24 hpi at P<0.05, P<0.01, and P<0.001 respectively. The 
MN/TX/NC NS virus had significantly lower titers than both NC/TX and TX/96 from 10-
24 hpi but then the titers recovered by about 36 hpi (Figure 3-4). 
 
 
pSREC Growth Kinetics 
 
 Preliminary growth kinetic experiments in primary swine trachea cells showed 
kinetics similar to what has previously been reported for in vivo experiments (Figure 
3-5). The human H3N2 virus (TX/96) grew to lower titers when compared to the swine 
viruses and the swine 6+2 viruses, as expected. This followed the pattern of lower titers 
and poor transmission when swine have been experimentally infected as has been 
previously reported and based on what has been seen epidemiologically.66  
 
 More extensive evaluation of the swine, human, and 6+2 viruses in the pSRECs 
revealed that there is little difference in growth abilities (Figure 3-6). The only 
significant difference observed was that TX/96 had a higher titer than MN/99 at 20 hpi 
(P<0.05). This was opposite of what was expected due to the preliminary kinetic results. 
 
 Additionally, the pSRECs were infected with the reassorted viruses to determine 
the effects that the different polymerase gene segments played on the distinct swine 
backbones. The NC-PB1 in MN/TX/NC-PB1 results in significantly lower viral titers at 
18 and 20 hpi (P<0.05) compared to MN/TX (Figure 3-7). During the early time points, 
MN/TX/NC-PB2 grows at lower titers 14 (P<0.001) and 20 hpi (P<0.05), while the 
NC/02-PA in the MN/TX/NC-PA virus causes viral growth deficiencies later at 36 hpi 
(P<0.05). Addition of both the PB2 and PA have cumulative effects in MN/TX/NC-PB2 
PA and attenuate the virus at 12 hpi (P<0.05), 12, 16 hpi (P<0.001), 18 hpi (P<0.05), and 
20 hpi (P<0.001). However, no growth defect is observed when the whole NC 
polymerase complex is exchanged for the MN polymerase trimer comparing 
MN/TX/NC-Pol to MN/TX. 
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Figure 3-4: MDCK growth of RG viruses with TRIG NS 
MN/TX/NC NS grows at a significantly slower rate compared to wt TX/96 and NC/TX at 
10-24 hpi (P<0.001). At 12 hpi MN/TX/NC NS grows at lower titers than MN/TX up 
through 24 hpi (p<0.05, p<0.01, and p<0.001, respectively). The asterisks denote time 
points with significant differences observed with the color matching the strain being 
compared. 
*** P<0.001 
** P<0.01 
* P<0.05 
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Figure 3-5: Preliminary pSREC growth kinetics at an MOI of 0.01 
Preliminary kinetic experiments in pSRECs mirrored other experiments where the swine 
viruses grow rapidly and to higher titers compared to the human virus, TX/96. These 
kinetic experiments were completed with only 1 replicate, so significance could not be 
calculated.  
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Figure 3-6: pSREC growth kinetics at an MOI of 0.01 
There were no significant differences between any of the viruses when compared to 
TX/96 except MN/99 at 20 hpi (P<0.05). The asterisks denote time points with 
significant differences observed with the color matching the strain being compared. 
*** P<0.001 
** P<0.01 
* P<0.05 
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Figure 3-7: Growth kinetics of RG viruses in pSRECs where the polymerase gene 
segments have been swapped on the MN/TX viral backbone 
The MN/TX/NC-PB1 virus grew to lower titers than MN/TX at 18 and 20 hpi (P<0.05). 
Compared to MN/TX, the NC/02-PB2 in MN/TX/NC-PB2 virus grows at lower titers 
during the early time points of 14 hpi (P<0.001) and 20 hpi (P<0.05), while the NC/02-
PA in the MN/TX/NC-PA virus causes viral growth deficiencies later at 36 hpi (P<0.05). 
Both the PB2 and PA have cumulative effects and attenuated the MN/TX/NC-PB2 PA 
virus at 12 (P<0.05), 14, 16 (P<0.001), 18 (P<0.05), and 20 hpi (P<0.001). When the 
complete NC polymerase is included in MN/TX/NC-Pol, the growth is no different than 
MN/TX. The asterisks denote time points with significant differences observed with the 
color matching the parental strain of the comparison. 
*** P<0.001 
** P<0.01 
* P<0.05 
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 When the classical swine PB1 was put into the TRIG polymerase complex with 
human H3N2 surface proteins, the PB1 attenuated growth of the virus at 14 (P<0.05), 20, 
and 36 hpi (P<0.01) compared to NC/TX as seen in Figure 3-8. There are no growth 
differences observed when the 3 TRIG polymerase segments from NC/02 are rescued 
with MN/TX in MN/TX/NC-Pol compared to the NC/TX virus. 
 
 Finally, the TRIG NS had no significant effect of MN/TX/NC-NS growth in 
pSRECs when compared to MN/TX (Figure 3-9). Although it had no significant 
difference, the addition of the TRIG NS does seem to cause a slight reduction in its 
growth especially 10-20 hpi, but the virus is able to recover around 24 hpi with an end 
point titer similar to TX/96, MN/TX, and NC/TX. 
 
 
Reassortant Swine Virus Infectivity and Transmissibility in Pigs 
 
 To confirm in vitro results, pigs were used to monitor infectivity and 
transmissibility of a selection of reassortant swine viruses with the human viral 
glycoproteins and one virus with the TRIG PB1 in the classical swine backbone. As 
expected, the pigs inoculated with wt TX/96 became infected but no virus could be 
detected in any of the contact animals (Figure 3-10). The viral titers peaked 1 to 3 dpi at 
103.667 and 104.5 TCID50 per ml, respectively. There was also no virus detected in the 
inoculated animals on day 7, so the virus had been cleared between 5 and 7 dpi. 
 
 Pigs inoculated with the TRIG PB1 reassorted with the classical swine 
polymerase in the RG virus MN/TX/NC-PB1 shed detectable virus up to 7 dpi. Like the 
TX/96 virus, none of the contact animals shed any virus (Figure 3-11). The virus was 
slightly attenuated when compared to the other tested viruses because it was only 
detected in one inoculated pig from 3-7 dpi and from 1-7 dpi in the other inoculated 
animal. This virus also only reached an average peak titer of about 103.987 TCID50 per ml 
5 dpi. 
 
 Interestingly, when the human HA and NA were rescued on the classical swine 
virus backbone (MN/TX), the virus established a robust infection, reaching an average 
peak titer of 105.282 TCID50 per ml 3 dpi (Figure 3-12). Beyond the relatively high titer 
and despite the presence of the HA and NA from a human virus, MN/TX was able to 
transmit to all three contact animals. Virus was first detected in the contact animals 
starting 3 dpi and the highest titers were detected 5 dpi in one of the animals and 7 dpi in 
the other two contact animals. However, the average peak titer was slightly lower in the 
contact animals at 105 TCID50 per ml. 
 
 Similar to MN/TX, when the human HA and NA were present on the TRIG 
cassette backbone (NC/TX), the virus reached relatively high titers in the inoculated 
animals as well as all three of the contact animals (Figure 3-13). However, the inoculated 
animals had peak titers 1 dpi with an average titer of 104.909 TCID50 per ml and the 
contacts had an average peak titer of 104.41 TCID50 per ml ranging from 3-7 dpi. Although  
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Figure 3-8: Growth kinetics of RG viruses in MDCK cells where MN-PB1 was 
swapped on the NC/TX viral backbone 
The NC/TX/MN-PB1 virus grew to significantly lower titers at 14 (P<0.05), 20, and 36 
hpi (P<0.01) compared to NC/TX. MN/TX/NC-Pol with the 3 polymerase segments from 
NC/02 does not show any significant growth defects when compared to NC/TX. The 
asterisks denote time points with significant differences observed with the color matching 
the parental strain of the comparison. 
*** P<0.001 
** P<0.01 
* P<0.05 
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Figure 3-9: Reassortant viruses with TRIG NS in pSRECs 
There were no significant growth differences between any of the viruses when compared 
to MN/TX. 
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Figure 3-10: Growth and transmission of human TX/96 in pigs 
Virus was detected and titers were determined by TCID50. Inoculated pigs became 
infected but the virus did not transmit to direct contact animals. The average peak titers 
reached 104.08 TCID50 per ml. 
* No virus detected from pig 149 likely the result of inadequate swab insertion. 
 
 
  
* 
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Figure 3-11: Growth and transmission of MN/TX/NC-PB1 in pigs 
Virus was detected and titers were determined by TCID50. Inoculated pigs became 
infected but the virus did not transmit to direct contact animals. The average peak titers 
reached 103.99 TCID50 per ml 5 dpi. 
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Figure 3-12: Growth and transmission of MN/TX in pigs 
Virus was detected and titers were determined by TCID50. Inoculated pigs became 
infected and the virus was capable of transmitting to all of the direct contact animals. The 
average peak titers in the inoculated animals reached 105.28 TCID50 per ml 3 dpi, while 
the contact animals reached an average peak titer of 105 TCID50 per ml 5-7 dpi. 
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Figure 3-13: Growth and transmission of NC/TX in pigs 
Virus was detected and titers were determined by TCID50. Inoculated pigs became 
infected and the virus was capable of transmitting to all of the direct contact animals. The 
average peak titers in the inoculated animals reached 104.91 TCID50 per ml 1 dpi, while 
the contact animals reached an average peak titer of 104.41 TCID50 per ml 5 dpi. 
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these titers are lower than MN/TX, the NC/TX virus was capable of reaching its peak 
titer several days earlier than MN/TX. 
 
 
Discussion  
 
 
In Vitro Reassortment 
 
 With the high throughput sequencing capabilities of the MiSeq platform, we were 
able to genotype a large number of viruses for both in vitro coinfection conditions. In 
previous coinfection experiments with the classical swine virus, no reassortants were 
detected.66 However, we see that MN/99 is capable of reassorting with TX/96 and 
produces a greater variety of viral genotypes than NC/02 and TX/96. When genotyping 
96 potential reassortant viruses, we identified 34 different reassortant viruses between 
MN/99 and TX/96 compared to only 19 reassortant genotypes between NC/02 and 
TX/96. However, 21% of the reassortants between MN/99 and TX/96 were only detected 
once, while only 10% of the reassortants between NC/02 and TX/96 were detected once. 
This suggests that although MN/99 reassorts more frequently than NC/02, many of the 
reassortants have relatively slower growth characteristics compared to the parental strains 
or other more prevalent reassortant genotypes. The different reassortant genotypes with 
the TX/96 HA and NA suggest there may be some gene incompatibility when comparing 
MN/99 and NC/02. On the classical swine backbone, both the TX/96 HA and NA occur 
together in 68.8% of the reassortants compared to only 18.8% of the reassortants on the 
TRIG backbone. Additionally, the TX/96 HA and NA occur alone only 10.8% and 
12.9%, respectively, on the classical swine backbone. Conversely, the TX/96 HA alone 
occurs 69.8% of the time on the TRIG backbone with the NA from NC/02 producing an 
H3N1 genotype. This particular genotype has been identified in swine but at very low 
frequencies suggesting this is a favorable genetic composition but it may be limited in its 
ability to infect in vivo or to transmit. These statistics are not conclusive for gene 
compatibility, but they suggest that the classical HA or NA is incompatible with the TX 
HA or NA, while the TX/96 HA appears frequently with the NC/02 NA suggesting they 
are highly compatible. There may also be some restrictions based on the different 
polymerase segments. In reassortant viruses with the H3 between MN/99 and TX/96, 
44.3% of the viruses contained all three polymerase segments from the human lineage 
virus while 55.7% contained at least one segment from MN/99 and one segment from 
TX/96. Similarly, 53.1% of the reassortant H3 viruses between NC/02 and TX/96 
contained at least one polymerase gene segment from NC/02 and at least one segment 
from TX/96. However, only 4.5% of the H3 viruses had all three gene segments from 
TX/96 and 46.9% had all three gene segments from NC/02. These percentages clearly 
demonstrate that the wholly NC/02 polymerase complex is more promiscuous in its 
ability to form viable viral genotypes with human H3 gene segments compared to the 
MN/99 polymerase gene segments.  
 
 There are very few gene segments that very strongly correlate as would have been 
expected if there were major gene incompatibilities. The strongest gene segment 
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correlation between MN/99 and TX/96 was between the M and NS segments. This is 
likely because the matrix protein interacts with the NEP protein as the RNPs are exported 
out of the nucleus for virion formation. This interaction is crucial for new budding virions 
to completely form as well as for efficient replication. 
 
 There are several strongly correlated gene segments between NC/02 and TX/96 
including, M and PA and M and NP. The correlation between M and NP likely plays a 
role in RNP export from the nucleus as well as viral packaging. The M and NP need to be 
able to efficiently interact because it has been suggested that this is a mechanism of 
“sensing” when all 8 gene segments have been incorporated into a new virion prior to 
budding. This correlation between M and PA is not well understood because there is no 
known interaction between the M and PA proteins. This may suggest that there is a 
protein interaction that has yet to be identified between the matrix and PA proteins. 
 
 
Early Kinetic Differences in MDCK Cells 
 
 To determine if gene incompatibility was the driving factor for lack of observed 
reassortment between classical swine viruses with human HA and NA versus TRIG 
viruses, the growth kinetics were completed to compare the parental strains with the 6+2 
reassortant viruses. There were no differences observed between the MN/99 parental 
strain when compared to the MN/TX virus. Similarly, there was no observable difference 
between NC/02 and NC/TX. This demonstrates that addition of the human HA and NA 
on the different swine backbones does not attenuate either virus and therefore was not the 
limiting factor for the epidemiologic observations in which the classical swine viruses did 
not reassort. 
 
 The primary differences observed were between 10 to 24 hpi when comparing 
TX/96, NC/02, and NC/TX to the kinetics of MN/99 and MN/TX. MN/99 and MN/TX 
showed significantly lower titers at 10, 12, 20, and 24 hpi when compared to the NC/02 
virus. This indicates that NC/02 and NC/TX have distinct growth advantages in the 
ability to initiate an infection and spread within the host when compared to MN/99 and 
MN/TX. This further suggests why the TRIG viruses have displaced the classical swine 
viruses, but does not provide evidence for the lack of classical swine virus reassortment. 
 
 To further explore if the polymerase gene segments affect genetic compatibility, 
multiple polymerase reassortants were rescued and growth kinetics were completed. 
Again, TX/96 and NC/TX proved to be the most fit kinetically out of the viruses tested. 
The other significant differences occurred when the TRIG PB2 and/or PA gene segments 
were rescued in the MN/TX virus. Unexpectedly, the polymerase reassortants with the 
TRIG PB2 and PA show reduced fitness suggesting that they may not be fully compatible 
with the cs PB1. Despite the observed differences, they only occur at the later time points 
of 24 through 48 hpi and do not occur during the full time course. Within this model, the 
addition of the TRIG PB2 and/or PA does not confer any growth advantage to MN/TX. 
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 Not only do the polymerase gene segments need to be well matched for efficient 
replication, even the NS1 and/or NEP proteins need to be matched with the other gene 
segments. The inclusion of TRIG NS in the MN/TX virus also disrupts viral growth 
efficiency. However, the effects are only noticeable between 12 and 24 hpi, as the end 
point viral titers are not different from the other tested viruses. This demonstrates a clear 
polygenic cooperation in these viruses when tested in MDCK cells. 
 
 
RG Virus Growth Kinetics in pSRECs 
 
 The growth kinetics in MDCK cells indicate that TX/96 grows more rapidly than 
either MN/99 or NC/02. However, other studies have shown that TX/96 does not 
efficiently replicate in swine,66 suggesting that the MDCK model is not adequate for 
swine virus studies. Preliminary growth kinetics in pSRECs from laboratory pigs 
mirrored previous studies in which the TX/96 virus grew at lower titers than either of the 
swine viruses. Additionally, the reassortant MN/TX and NC/TX viruses grew to similar 
titers as MN/99 and NC/02.  
 
 Despite the promising results of the initial studies, when the growth kinetics were 
repeated in pSRECs derived from naturally farmed swine, there were no kinetic 
differences between any of the viruses except TX/96 and MN/99 at 20 hpi. These 
differing results can be explained by several factors. The use of primary cells from 
varying sources can lead to inconsistent results as seen here. Additionally, the pSRECs 
used for the initial studies included epithelial cells from beyond the bronchi bifurcation 
and included some bronchioles. The later experiments only used cells harvested from the 
trachea. It is possible that these factors could have contributed to a differing receptor 
expression patterns on the cells used, although, the upper and lower respiratory tracts of 
swine predominantly express α2,6 linked sialic acids.82 It is also possible that the pigs 
used for the latter experiments had previous exposure to influenza viruses and may have 
had some preexisting immunity that was present during the experiment.  
 
 Further growth kinetics were completed to determine if the reassorted polymerase 
complex had any effects on viral growth in the pSRECs. Similar to growth kinetic results 
in MDCK cells, there are identified time points where the viral kinetics were significantly 
different, but no viruses showed consistent attenuation when compared to the other tested 
viruses. One genotype that matched the results seen in MDCK cells was MN/TX/NC-
PB2 PA. This virus grew at significantly lower titers at 12-20 hpi compared to MN/TX. 
Furthermore, when the whole TRIG polymerase complex is rescued in the MN/TX virus, 
the virus is no longer attenuated. This strongly suggests that the polymerase complex 
must be well matched for efficient replication and that the TRIG PB2 and PA do not 
efficiently interact with the classical swine PB1. 
 
 When the TRIG NS is rescued in the MN/TX virus, there is no significant 
difference observed in the growth kinetics using pSRECs, however, the MN/TX/NC-NS 
virus does show some slight attenuation 10-20 hpi. This is different than what was seen in 
MDCK cells in which the MN/TX/NC-NS virus was significantly attenuated. This 
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suggests that introduction of the TRIG NS causes some incompatibility but this 
incompatibility can be overcome in the swine cells. One possible explanation for 
overcoming the incompatibility in the pSRECs is that the TRIG NEP more specifically 
interacts with swine CRM1 than canine CRM1 thereby reducing the effect of a new gene 
segment. CRM1 has been shown to mediate protein export from the nucleus and is 
conserved among species. 
 
 
Swine Backbones Restore Transmission in Vivo 
 
 Pigs were infected with the wt TX/96 and the reverse genetic NC/TX, MN/TX, 
and MN/TX/NC-PB1 viruses to test the ability of swine viruses with human H3 and N2 
surface glycoprotein to infect and transmit. As expected, TX/96 did not transmit to any of 
the contact animals despite establishing an infection in the directly inoculated animals. 
One of the inoculated animals did not have a titer on day 3 but had titers on 1 and 5 dpi. 
This was likely the result of poor swabbing. The virus was cleared by both infected 
animals by day 7 post infection. 
 
 Similarly, when MN/TX/NC-PB1 was used for inoculation, the two inoculated 
animals became infected and all three contact animals remained negative throughout the 
experiment. However, both MN/TX and NC/TX were able to transmit to 100% of the 
contact animals. This indicates that disruption of the MN polymerase complex with the 
TRIG PB1 causes a decrease in viral growth as well as diminishes its ability to transmit.  
 
 Most surprising is the ability of the MN/TX and NC/TX viruses to transmit to all 
contact animals. The MN/TX virus appeared in contact animals starting 3-5 dpi and was 
detected for about 6 days prior to clearance. The duration of viral shedding and peak 
titers were similar between inoculated and contact animals. This provides compelling 
evidence that HA and NA are not the primary host determinant factors, but rather the 
interaction of the internal gene products with each other and with host proteins. However, 
this experiment cannot rule out a virus’ inability to infect a host due to poor receptor 
recognition. 
 
 Additionally, NC/TX 6+2 showed similar growth characteristics to MN/TX. 
NC/TX transmitted to all three contact animals starting 3-5 dpi and could be detected for 
4-6 days prior to clearance. Inoculated animals had similar peak titers to contact animals 
and these peak titers were also comparable to those seen with MN/TX. However, NC/TX 
appears to reach peak titers 1 to 2 days before MN/TX. The pigs inoculated with NC/TX 
peaked 1 dpi and the contact animals reached peak titers 3-5 days post inoculation. The 
peak titers of MN/TX were delayed 1-2 days when compared to NC/TX in that the 
inoculated animals reached peak titers 3 dpi and the contact animals reached peak titers 
5-7 dpi. This indicates that the TRIG backbone provides an inherent growth advantage 
because the TRIG viruses can reach peak titers more rapidly and therefore establish a 
productive infection prior to the viruses with the classical swine backbone. 
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Conclusions 
 
 The success of influenza viruses with the TRIG cassette is difficult to dispute due 
to the high epidemiologic prevalence in U.S. swine herds. This success can be attributed 
to the virus’ ability to rapidly establish an infection when compared to the classical swine 
viruses. However, incorporating the TRIG polymerase heterotrimer into the classical 
swine virus does not confer this rapid viral replication phenotype suggesting that the 
growth advantage seen in the TRIG viruses is a trait inferred by the other segments or 
optimized gene and protein interactions. It does lend evidence for why the TRIG viruses 
displaced the classical swine viruses, but cannot provide an answer for how reassortment 
was restricted in classical swine viruses. The data suggests that there is no virologic 
reason for why the classical swine viruses did not reassort because they are capable in in 
vitro experiments. In vivo experiments also demonstrated that the human H3 and N2 
segments were capable of infecting and transmitting. This indicates that there are other 
factors, including host and environmental, that caused the epidemiologically observed 
differences in reassortment between the TRIG viruses and classical swine viruses. 
 
 The HA and NA are regarded as the main contributors of host restriction. 
However, when rescued on different backbones, the same viral glycoproteins can show 
transmissible phenotypes and restricted phenotypes. This suggests that host restriction 
can also be attributed to some aspects of the internal genes. This data only confounds the 
questions further as to why no reassortants were seen with the classical swine virus 
backbone. 
  
 59 
CHAPTER 4.    EVOLUTIONARY BURST OF REVERSE GENETIC VIRUSES 
PASSAGED IN SWINE EPITHELIAL CELLS 
 
 
Introduction 
 
 The classical swine HAs underwent minimal antigenic drift during roughly 80 
years of circulation in U.S. swine herds. This is largely the result of minimal immune 
pressure due to the limited life span of farmed swine as well as the continual introduction 
of young naïve piglets for growing and finishing.62 However, once the TRIG cassette 
formed within the swine viruses, there was a considerable increase in genetic 
reassortment as well as increased genetic drift.63 The increased genetic variation has yet 
to be fully explained.  
 
 Several hypotheses have been proposed for why the TRIG provides this 
evolutionary burst, but they have not been extensively examined experimentally as of yet. 
The increased growth kinetics resulting from the optimized polymerase complex could 
afford greater statistical probability that a virus with beneficial mutations would arise and 
be capable of becoming the dominant viral species within the population, thus 
transmitting to new hosts. The RNA dependent RNA polymerase complex is inherently 
inaccurate during replication, so more virus progeny are produced increasing the 
probability of successful variants. Another possibility is that the TRIG NS provides an 
initial growth advantage for the virus by greater suppression of the host interferon 
response (P. Thomas, personal communication, October 13, 2010). This early burst of 
replication may provide an opportunity for increased viral variants, some of which may 
have advantageous mutations. Where more research is needed, recent computational 
modeling reveals that viruses containing the TRIG cassette as well as the TRIG NS 
appear to undergo accelerated nucleotide substitution when compared to viruses that lack 
these internal genes.83 The epidemiologic data and phylogenetic analysis suggests there is 
a strong relationship between the TRIG cassette and NS leading to increased evolution of 
the HA and the virus as a whole. The increased propensity for reassortment and the 
evolutionary burst could have significant implications for influenza evolution, host 
adaption, and human health.  
 
 The increased promiscuity of the TRIG polymerase complex increases the 
possibility of incorporation of novel HAs on the TRIG backbone as well as the ability to 
more readily adapt to a new host. This has important implications for agricultural health 
especially if more virulent viruses are able to reassort with the TRIG and transmit among 
the pig population. This scenario also poses serious implications for public health. With 
the emergence of the TRIG in the human population during the 2009 H1N1 pandemic, 
the opportunities of reassortment with novel avian and highly pathogenic avian HAs has 
increased. Along with the risk that these novel HAs can more readily adapt to the human 
host receptors raising the likelihood for sustained transmission. Additionally recent 
studies have indicated that as few as five mutations are required for highly pathogenic 
H5N1 viruses to transmit via aerosol contact between ferrets.84,85 The evolutionary 
characteristics of the TRIG cassette and TRIG NS need to be further investigated in order 
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to better understand how influenza viruses will continue to evolve and the risks posed to 
swine and human health. 
 
 
Material and Methods 
 
 
Viruses 
 
 Multiple reverse genetics viruses were rescued based around the RG-MN/99 
classical swine H1N1 virus, the RG-NC/02 triple reassortant H1N1 virus, and TX/96 
human H3N2 virus. The RG viruses were generated using the dual promoter eight 
plasmid system as outlined in Figure 2-1.70 The rescued virus supernatants were then 
injected into 10 day old embryonated chicken eggs and incubated at 35°C for 48 hours. 
The allantoic fluid is harvested and re-injected into embryonated chicken eggs for a 
second passage. The virus was harvested, aliquoted, and stored at -80°C. Each vial was 
only thawed once before use in each experiment. All of the genotypes used for the viral 
passage experiments are identified in Table 3-1. 
 
 
Viral Passaging in pSRECs 
 
 The pSRECs were grown on collagen coated tissue culture plates to about 80-90% 
confluence and the cells were washed with 1X PBS. The HA titer was determined for 
each virus using 0.5% (v/v) turkey red blood cells. Prior to infecting the cells, each virus 
was diluted to an HA unit of 1 (the minimal amount of virus required to prevent 
agglutination of red blood cells), in a total of 3 ml of infection media. The pSRECs were 
then infected with 1 ml of the virus dilution and incubated at 37°C with 5% CO2 for 1 
hour. The viral dilutions were then washed from the cells using 1X PBS and infection 
media with 0.5 µg/ml TPCK-Trypsin. 
 
 The cells were monitored daily for cytopathic effect (CPE). CPE is change in 
observable cellular morphology resulting from infection or natural cell death. When the 
cells reached a CPE score of 2-3, the viral supernatant was collected and a 1 ml aliquot 
was stored at -80°C and the HA titer was determined using a portion of the remaining 
volume. The viruses were again diluted to an HA titer of 1 and used to infect a new 80-
90% confluent well of pSRECs. If there was no detectable HA titer, the virus was diluted 
at 1:8 and this dilution was used for pSREC infection. This process was repeated for a 
total of 6 viral passages. 
 
 
Viral Sequencing 
 
 To determine a relative nucleotide substitution rate, the HAs of the cell-1 (C1) 
passage, egg-1 (E1) passage, and egg-2 (E2) passage of each rescued virus were all 
sequenced using the MiSeq Illumina platform as described in chapter 3 using the Bioo 
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Scientific NEXTflex sequencing kits (catalog number 5140-02). Nucleotide variations 
were determined using the CLC Genomics Workbench 6.0.1 quality-based variant 
detection algorithm. 
 
 
Results 
 
 
Viral Passaging in pSRECs 
 
 We observed a decline of HA titers for several viruses over the course of the 
initial viral passaging experiment. The classical swine virus with the TRIG PB2 and PA 
showed a gradual decrease from an HA titer of 64 at viral passage (vPx) 2 to a titer of 16 
at vPx 4 (Figure 4-1A). This was similar to NC/TX/MN-PB1 which the HA titer had 
decreased from 64 to 32 in vPx 2 to a titer of 0 by vPx 4. Numerous viruses resulted in an 
HA titer of 0 by the fourth passage, including MN/TX, TX/96, MN/TX/NC-NS, and 
MN/TX/NC-PB1. The only virus that maintained a relatively stable HA titer was NC/TX 
with a titer of 64 for all 4 passages. All of the viruses that maintained an HA titer through 
four passages, had an avian PB2 and/or PA gene segment constellation in the polymerase 
complex, except for NC/TX/MN-PB1 (Table 4-1). 
 
 To confirm that the reduction in HA titer was not a random occurrence, the 
passaging experiment was repeated and all viruses were passaged 6 times in the pSRECs 
even if the HA titers dropped below detectable levels. Like the previous experiments, 
NC/TX maintained an HA titer for all 6 passages, although the titers did decrease at vPx 
2 and increased to a titer of 128 by vPx 5 (Figure 4-1B). As with the first trial, many of 
the viruses showed decreasing titers around vPx 4, however, after continuing passaging 
within the pSRECs, viruses recovered titers including MN/99, MN/TX/NC-NS, 
MN/TX/NC-PB1, and MN/TX/NC-PA. Despite a similar pattern of HA titer decrease and 
recovery, only 2 viruses showed this commonality between the 1st and 2nd experiments 
(Table 4-2). Unexpectedly, NC/02 showed a decreasing titer through vPx 3 and did not 
recover. 
 
 Surprisingly, when TCID50 titers were determined for all of the viruses from the 
first experiment, all of the viruses maintained TCID50 titers for all passages except 
MN/TX/NC-PB1 which had no detectable titer after the 4th passage (Figure 4-2). Even 
more interesting is that as the HA titers were decreasing up to passage 4, the infectivity 
titers were all increasing from passage 3 to 4. 
 
 
TRIG NS Evolutionary Burst 
 
 Deep sequencing data of the human H3 on the classical swine backbone, TRIG 
backbone, and classical swine with TRIG NS revealed very few nucleotide substitutions. 
There was one nucleotide substitution identified in the H3 on the classical swine 
backbone at position 1179 from the C1 to the E1 passage (Figure 4-3A and Table 4-3).   
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Figure 4-1: HA titers of viruses during passaging within pSRECs 
A) Shows HA titer over the course of viral passages in the pSRECs up the passage 4. B) 
Shows HA titers for a 2nd experiment over the course of 6 viral passages in the pSRECs. 
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Table 4-1: Viral genotypes and gene constellations for pSREC passage 
 
Virus PB2 PB1 PA HA NP NA M NS 
NC/TX NC NC NC TX NC TX NC NC 
MN/TX MN MN MN TX MN TX MN MN 
TX/96 TX TX TX TX TX TX TX TX 
MN/TX/NC-
NS MN MN MN TX MN TX MN NC 
MN/TX/NC-
PB1 MN NC MN TX MN TX MN MN 
NC/TX/MN-
PB1 NC MN NC TX NC TX NC NC 
MN/TX/NC-
PB2 PA NC MN NC TX MN TX MN MN 
MN/TX/NC-
PB2 NC MN MN TX MN TX MN MN 
MN/TX/NC-
PA MN MN NC TX MN TX MN MN 
 
The orange boxes symbolize gene segments sourced from the TRIG virus NC/02, Blue 
boxes indicate gene segments of classical swine lineage and the green boxes are genes 
from the human H3N2 virus, TX/96. The yellow highlighted RG viruses maintained HA 
titers through the 4 pSREC passages. The viruses with no color had an HA titer crash 
with no recovery. 
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Table 4-2: Viral genotypes and gene constellations for pSREC passaging after 6 
viral passages 
 
Virus PB2 PB1 PA HA NP NA M NS 
NC/02 NC NC NC NC NC NC NC NC 
NC/TX NC NC NC TX NC TX NC NC 
MN/99 MN MN MN MN MN MN MN MN 
MN/TX MN MN MN TX MN TX MN MN 
TX/96 TX TX TX TX TX TX TX TX 
MN/TX/NC-
NS MN MN MN TX MN TX MN NC 
MN/TX/NC-
PB1 MN NC MN TX MN TX MN MN 
NC/TX/MN-
PB1 NC MN NC TX NC TX NC NC 
MN/TX/NC-
PB2 PA NC MN NC TX MN TX MN MN 
MN/TX/NC-
PB2 NC MN MN TX MN TX MN MN 
MN/TX/NC-
PA MN MN NC TX MN TX MN MN 
 
The orange boxes symbolize gene segments sourced from the TRIG virus NC/02, Blue 
boxes indicate gene segments of classical swine lineage and the green boxes are genes 
from the human H3N2 virus, TX/96. The yellow highlighted RG viruses maintained HA 
titers through the 6 pSREC passages. The viruses with no color had an HA titer crash 
with no recovery. 
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Figure 4-2: Infectivity titers of the RG viruses after serial passaging in pSRECs 
TCID50 titers determined for RG viruses over the course of 4 passages in pSRECS. 
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Figure 4-3: Comparison of quality-based variant detection results between 
MN/TX, NC/TX, and MN/TX/NC-NS 
A) Nucleotide variant detection for HA of MN/TX passage C1 through E2. The blue 
graph indicates HA segment read coverage and the orange bar graph identifies location 
and prevalence of variants. B) Nucleotide variant detection for HA of NC/TX passage C1 
through E2. The blue graph indicates HA segment read coverage and the orange bar 
graph identifies location and prevalence of variants. C) Nucleotide variant detection for 
HA of MN/TX/NC-NS passage C1 through E2. The blue graph indicates HA segment 
read coverage and the orange bar graph identifies location and prevalence of variants. 
The 2 common variants identified on the 5’ and 3’ ends of all data sets include mutations 
derived from the universal primers. 
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Table 4-3: Nucleotide position and frequency of detected variants 
 
  MN/TX  NC/TX  MN/TX/NC-NS  
Virus 
passage  
Nucleotide 
position 
Percent of 
population  
Nucleotide 
position 
Percent of 
population  
Nucleotide 
position 
Percent of 
population  
C1     1177 6.33%  98 13.33%  
E1  1179 12.66%  1177 7.55%  233 9.09%         1177 6.19%  
E2 
 462 16.67%  1177 6.06%  457 29.03%  
 624 8%     458 38.71%  
 637 21.74%     462 8%  
       463 8.33%  
       660 9.52%  
       1177 5.85%  
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This mutant made up 12.66% of the population but was undetectable from the viral 
population in the E2 passage. However, the E2 passage resulted in 3 new nucleotide 
mutations compared to the C1 passage at positions 462 (16.67%), 624 (8%), and 637 
(21.74%). 
 
 Despite the presence of the TRIG NS in the NC/TX virus, through all three virus 
passages, only 1 variant was detected (Figure 4-3B). This variant was detected at 
nucleotide position 1177. This variant is identified in all 3 passages; however it only 
occurs at relatively low frequency, ranging 7.55% at passage E1 to 6.06% at passage E2 
(Table 4-3). 
 
 Interestingly, when the TRIG NS is rescued on the classical swine backbone and 
human H3N2 surface proteins, there seem to be an increased number of nucleotide 
mutations. In the C1 passage, 1 variant was detected at position 98 (13.33%) as seen in 
Figure 4-3C. By passage E1 the nucleotide variant at position 98 was no longer detected 
in the population and was replaced by 2 other variants at positions 233 (9.09%) and 1177 
(6.19%). In the E2 passage, the variant at 1177 was maintained in the population at 
5.85% and 5 additional variants were detected. The first 4 variants were detected close 
together at positions 457 (29.03%), 458 (38.71%), 462 (8%), and 463 (8.33%). The final 
variant identified made up 9.52% of the population at position 660 (Table 4-3).  
 
 
Discussion 
 
 
Viral Passages in pSRECs Do Not Mirror Nature 
 
 The passaging experiments in pSRECs were conducted to determine evolutionary 
rates, but some viruses did not have the ability to maintain productive infections through 
multiple passages. However, further investigation revealed that although the HA titers 
had become undetectable, most of the TCID50 titers were maintained albeit they were 
decreasing through passage 3. All of the viruses except MN/TX/NC-PB1 showed 
increasing titers from passage 3 to 4. Coincidentally, MN/TX/NC-PB1 also failed to 
transmit in the pig experiments. However, when the passaging experiment was repeated, 
several viruses showed unexpected HA titer crashes including NC/02, MN/TX/NC-PB2 
PA, and MN/TX/NC-PB2. These were unexpected because NC/02 has proven to be 
successful in swine and MN/TX/NC-PB2 PA and MN/TX/NC-PB2 were able to maintain 
HA titers in the initial experiment. Despite these inconsistencies, the overall HA titer 
patterns are similar between both experiments. The titers in general seem to continue to 
decrease up to vPx 4 and then in the second experiment many HA titers recover. This 
could be an indication of the viruses switching receptor specificities. All of the viruses 
used were previously passaged twice in eggs to obtain sufficient viral titers and volumes 
for experiments. When used in the pSRECs, the viruses may need to adapt back to the 
swine receptors.  
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The TRIG NS Does Cause an Evolutionary Burst on the Classical Swine Backbone 
 
 Deep sequencing of the TX/96 HA on several different backbones revealed 
different nucleotide substitutions. The NC/TX appeared the most stable with a single 
nucleotide substitution, at nucleotide position 1177 that appeared in all 3 passages but 
remained a relatively small proportion of the population despite being maintained. This 
could likely be a complimentary mutation which is matched with one or more mutations 
in another segment(s). Interestingly, the nonsynonymous substitution at 1177 or nearby at 
1179 appeared in the other viruses as well. The MN/TX virus had 4 nucleotide variants 
over the course of the 3 passages suggesting that the virus is more prone to mutation than 
NC/TX. This is further supported in that the nucleotide substitution in the E1 passage 
becomes undetectable following the E2 passage. These multiple changes indicate a higher 
nucleotide substitution rate, but a larger sample size with more passages would be 
required to confirm. Finally, MN/TX/NC-NS showed the most nucleotide substitutions in 
the TX HA. Through the course of the 3 passages there were 6 total nucleotide variants in 
the HA segment. Most of these cause amino acid substitutions in the globular head 
around the receptor binding site. This indicates that there is greater instability in the 
MN/TX/NC-NS virus compared to the other 2 viruses. But, if it was solely attributed to 
the TRIG NS, then an increased number of substitutions should have been detected in the 
HA of NC/TX. So, the greater instability in the HA of MN/TX/NC-NS could be the result 
of an additional foreign segment. This experiment is largely limited to the number of 
passages as well as sequencing limitations. In order to reduce sequencing inaccuracies, 
the threshold for variant detection needs to be set high enough to eliminate background 
substitutions. This could potentially mask the detection of many other minor variants. 
The study also needs an increased number of segments to be sequenced to determine if 
the genetic instability is observed in all of the gene segments and try to identify 
complimentary mutations. 
 
 
Conclusions 
 
 Initial data suggested that the classical swine virus may not have reassorted in 
nature because transmission could not be sustained in swine. However, this trend was not 
observed in the later experiments described in this chapter. It is possible that the 
experimental passages were not continued long enough for all viruses to reach sufficient 
concentration to be detected by the HA assay. The variability of the primary cell model 
may also lead to the viral titer crashes observed.  
 
 Preliminary studies also support the role of the TRIG NS in viral evolution. 
However, it cannot be excluded that the additional reassorted gene segment is responsible 
for the increased nucleotide substitutions rather than the TRIG NS itself. Many factors 
could be responsible for the increased nucleotide substitution frequencies; however, this 
study provides a new technique that can be used to study viral evolution through the 
detection of minor variants.  
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CHAPTER 5.    GENERAL DISCUSSION, CONCLUSIONS, AND FUTURE 
DIRECTIONS 
 
 
 Swine have often been postulated as the primary mixing vessel for the generation 
of pandemic viruses because they are a susceptible host for both avian and mammalian 
influenza viruses. However, there is no direct link between pigs and the pandemic viruses 
from 1918, 1957, and 1968. Prior to the 2009 H1N1 pandemic, the specific pandemic 
genotype had not been detected or isolated from swine but following the pandemic, there 
have been numerous viruses isolated from swine with the pandemic genotype. There have 
also been numerous reassortant viruses isolated from swine with the TRIG cassette. 
Swine viruses containing the TRIG cassette have shown increased viral diversity since 
the TRIG introduction around 1998. This is in stark contrast to the swine virus stability 
observed for the roughly 80 years prior to the TRIG formation. This study set out to 
determine what virologic mechanisms are responsible for the promiscuity of the TRIG or 
what restrictions are present in the classical swine viruses that prevented reassortment. 
 
 The data presented in this dissertation suggests that there is no distinct virologic 
factor that prevented the classical swine viruses from reassorting compared to the TRIG 
viruses. As found in many of the experiments, there were trends to suggest that MN/99 
was slightly less adept at reassorting when compared to the NC/02. The numerous small 
differences observed do suggest that MN/99 cannot reassort as readily as NC/02.  This 
phenomenon can also be explained by the transition from traditional pig farming to 
intensive farming that occurred starting in the late 1980s to the late 1990s. Traditional pig 
farming entailed relatively small farms which raised pigs from birth to market with 
limited movement between different herds. Intensive farming consists of very large farms 
with specialized functions. The pigs are farrowed and weaned at one farm and then 
transferred to another farm for growing and in some instances transferred again for 
finishing prior to being sent to market. Intensive farming leads to significantly more 
opportunities for pigs from different farms to interact at the different stages of growth, 
and these interactions increase the possibility for different influenza viruses to transmit 
among the herds and reassort. 
 
 The data shows that the classical swine virus and TRIG virus are able to 
superinfect cells with the human H3N2 virus, albeit, the classical swine virus does show a 
reduced number of superinfected cells. The results also indicate that the classical swine 
viruses are capable of reassortment similarly to the TRIG virus however, when the 
classical virus was grown with gene segments from the TRIG, it is slightly attenuated. 
This could be explained by the previous 80 years of evolution. These classical swine 
viruses were stable for so long because they had optimized their genetic composition. 
Ultimately, the generation of the TRIG resulted in viruses with a significant growth 
advantage over the classical swine viruses resulting in its ability to supplant the classical 
viruses as the dominant viruses in U.S. swine herds.  
 
 Unexpectedly, not all of the cells were infected during the flow cytometry 
superinfection experiment. This indicates that there are additional mechanisms preventing 
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cellular infection that could also be preventing superinfection other than NA expression. 
It is possible that the uninfected cells are in an IFN induced antiviral state; however, 
MDCK cells do not produce a very robust IFN response. It is also possible that DI 
particles are being produced by these viruses and these interfering particles are reducing 
the viral efficiency to infect all of the cells. To test these scenarios, the experiment should 
be repeated with IFN incompetent cells to prevent naïve cells from entering an antiviral 
state. Additionally, a fluorescent in situ hybridization assay can be performed to identify 
if the uninfected cells contain any viral segments. This would provide evidence of DI 
particle interference by entering the cell but not establishing a productive infection. The 
viral supernatant could also be used for next generation sequencing to identify if any viral 
populations contain deletions leading to DI particle formation. 
 
 None of the data suggested that the TRIG was more capable of reassorting than 
the classical swine virus, however, the in vitro reassortment data shows that the 
reassortants generated with the TRIG virus tend to be more fit than those generated with 
the classical swine virus. Despite this, there were unexpected results. The most prevalent 
viral genotype detected (34.4%) between the TRIG and H3N2 virus was an H3N1 virus 
on the TRIG backbone. The first H3N1 viruses were isolated from swine around 2004 
and the prevalence has been very low. This is contradictory to what is seen in vitro. This 
suggests that the H3N1 genotype is a favorable gene composition; however, the virus 
may have difficulty transmitting. To determine the optimal genotypes for infectivity and 
transmission, the in vitro reassortment viral supernatant should be used to inoculate naïve 
pigs with contacts. The results would suggest what viral genotypes are optimal for 
infection and transmission. Additionally, it will indicate if the H3N1 viral genotype is 
hindered in its ability to transmit because a large percentage of the inoculating virus will 
consist of this H3N1 virus.  
 
 Another major finding of this project is the role that the internal gene segments 
play in viral transmission. The in vivo transmission experiment clearly demonstrates that 
the TX/96 virus is not capable of transmitting in pigs, but when the HA and NA from the 
TX/96 virus are rescued on the swine virus backbones, these reverse genetics 6+2 viruses 
are capable of transmitting among pigs. This could have significant consequences if the 
viral backbone can also allow avian HA and NA combinations to infect and transmit in 
mammalian hosts, especially because pigs and humans are immunologically naïve to 
many subtypes of influenza viruses. The increased transmissibility of different HA and 
NA gene segments needs to be further explored, especially by rescuing avian viral 
surface glycoproteins on the different swine virus backbones. Additionally, the viruses 
that are capable of transmission can be sequenced to compare whether the avian HAs 
mutate to preferentially bind to mammalian receptors, or if the internal gene segments 
can overcome this barrier. 
 
 Although this study shows the increased fitness of viruses with the TRIG cassette 
compared to viruses based on the classical swine backbone, it is narrowed by the use of 
mammalian adapted viral surface glycoproteins. It will be important to further study the 
ability of the TRIG to reassort with avian lineage HA and NA gene segments. 
Additionally, it will be important to look at the ability of these viruses to adapt to 
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mammalian type receptors. Some preliminary data suggests that the TRIG virus with 
novel glycoproteins is relatively stable, but this needs to be further analyzed due to the 
very limited number of viruses sampled. This would also benefit from analyzing the 
number of changes that occur in avian origin HA and NA gene segments on the different 
backbone in a mammalian model. This data will help to better model the adaptation rate 
if the avian HA and NA glycoproteins were to cross the species boundary on the TRIG 
backbone. These experiments also demonstrate that the incorporation of the TRIG NS 
does increase the number of nucleotide changes in the HA gene segment around the 
receptor binding domain compared to not having a new gene segment. The initial 
hypothesis was that the TRIG NS was more efficient at inhibiting the IFN response 
leading to increased viral replication and diversity. This has since been shown to not be 
correct and that the TRIG virus evades the innate response by some other mechanism. 
Due to this information and the observed results, I believe that the increased nucleotide 
substitution rate is the result of a foreign gene segment rather than specifically the TRIG 
NS. The phylogenetic data shows an evolutionary burst, but all of the viruses undergoing 
the burst are identified with at least one gene segment from a different virus. If a different 
gene segment other than the TRIG NS was rescued in the MN/TX virus, it would also 
likely cause increased nucleotide substitutions as well. The introduction of these 
genetically different gene segments likely causes a disruption of certain protein-protein 
interactions leading to destabilization of the genome. It remains unclear as to whether this 
destabilization is spread throughout the genome equally or if there are particular proteins 
that undergo increased nucleotide substitution rates. Further experiments should look at 
substitutions throughout the genome when different gene segments are introduced to 
pinpoint if any of the 8 segments plays more of a role in the observed evolutionary burst 
as well as to determine if the whole influenza virus genome undergoes the evolutionary 
burst. 
 
 Viruses with the TRIG cassette not only have become the predominant viral 
genotypes in swine, but with the 2009 pandemic, the TRIG backbone has become one of 
the predominant viral genotypes in humans as well. This is of particular concern, because 
the TRIG has shown that it is capable of reassorting frequently and it has acquired novel 
HA and NA gene segments in its relatively short evolutionary history. Additionally, data 
presented here suggests that host restriction can be overcome by the internal gene 
cassette, whether it is based on the classical swine backbone or the TRIG cassette. With 
the current dominance of the TRIG in viruses isolated from both swine and humans, the 
possibility of reassorting with novel surface glycoproteins is greatly enhanced. 
 
 Not only does the TRIG show a promiscuous history, but data in this study show 
that it has the ability to rapidly establish an infection and transmit rapidly. This could 
easily explain why the 2009 pandemic virus was able to circulate globally in such a short 
period of time. This characteristic poses a serious problem for agricultural health and 
public health. If it does acquire novel viral glycoproteins of increased pathogenicity, it 
will be able to infect a larger proportion of the population prior to its detection and 
control which could result in significantly more morbidity and mortality than slower 
growing viruses. 
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 Finally, this study demonstrates that host restriction is clearly a polygenic 
characteristic that needs to be further explored. The TRIG provides a backbone that has 
the proven ability to reassort and grow with HA and NA surface proteins from different 
lineage viruses. It has also proven that it can infect and rapidly transmit in the human and 
swine populations. This provides an ideal combination for further generation of novel 
genotypes that can enter the human population, quickly adapt, and rapidly circulate. This 
study provides the foundation of how the TRIG backbone has become so dominant in 
influenza viruses today, but suggests that much more work needs to be conducted to 
identify what unique traits give it its evolutionary advantage. This study also 
demonstrates that although the viruses have some differences in their abilities to reassort, 
the ecology of the hosts also plays a significant role in viral reassortment and evolution. 
These traits will help drive increased influenza evolution in humans and swine 
throughout the U.S. and the world. Therefore, influenza A surveillance in both swine and 
humans needs to be continued to identify the emergence of novel viruses before they 
become a public health and agricultural problem.  
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 ANTIBODY PURIFICATION FROM ASCITES FLUID APPENDIX A.
 
 
1) Delipify the ascites fluid 
a. Use 1g Liposorb per 25ml ascites at 1-5 mg/ml (Calbiochem #524371 
PHM-L Liposorb Absorbent) to bind lipoproteins in the sample (1g will 
bind > 50 mg lipoprotein) 
b. Incubate at 4°C 1 hour to overnight 
c. Centrifuge at 1000 x g for 5 min 
d. Pipet ascites into new tube 
2) Dilute ascites 
a. Dilute delipified ascites fluid to 1:50 (add 49ml 1XPBS to 1ml ascites) 
b. Filter diluted ascites through a 0.2μm filter to remove any remaining 
liposorb 
3) Bind antibody to Protein G column 
a. Use a 1ml HiTrap Protein G column (GE Healthcare #17-0404-01 1ml 
HiTrap Protein G HP column) Avoid air bubbles in column by filling top 
nozzle with liquid and then secure syringe connector 
b. Wash column with 5 column volumes of ddH2O (5ml) 
c. Wash column with 5 column volumes 1XPBS (5ml) 
d. Add 50 ml diluted ascites fluid and pass through filter with 60 ml syringe 
(keep all flow through) 
e. Wash column with 20 column volumes of 1XPBS (20ml) (Save flow 
through) 
f. Check optical density (O.D.) absorbance at 280nm (A280) of the flow 
through  
g. If >0.002 then continue washing with 1XPBS. If <0.002 then elute 
antibody. (A280 should be close to 0) 
4) Elute antibody 
a. In five 1ml tubes add 100μl of 1M Tris-HCl pH 8.0 
b. Elute antibody with 5 column volumes (5ml) of 0.1M Glycine-HCl pH 2.7 
i. Collect in 1ml fractions in tubes with 100μl of 1M Tris-HCl pH 
8.0 
c. Invert tubes to neutralize low pH 
5) Measure O.D. of fractions 
a. Blank spectrophotometer with 1:10 dilution of 1M Tris-HCl pH 8.0 in 
0.1M Glycine-HCl pH 2.7 (100μl of 1M Tris-HCl pH 8.0 in 1ml of 0.1M 
Glycine-HCl pH 2.7) 
b. Measure absorbance of each fraction at 280nm to quantify and determine 
purity of purified antibodies 
6) Column Storage 
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a. Wash column with 10 column volumes (10ml) of 1XPBS 
b. Wash column with 10 column volumes (10ml) of ddH2O 
c. Add 5 column volumes (5ml) of 20% Ethanol 
d. Seal ends of column and store at 4°C 
7) Antibody Desalting (Desalt for labeling) 
a. Use Zeba desalting column and follow buffer exchange protocol. 
 
Antibody Isotyping (Mouse sourced antibody) 
1) Coat 6 wells per antibody of an ELISA plate with antibody target (HA or 
disrupted virus) 
a. Add 50μl/well of HA or disrupted virus  
b. Incubate at 4°C overnight 
c. Wash wells 3 times with 1XPBS + 0.05% Tween 20 
2) Block wells 
a. Block wells with 300μl 1XPBS + 10% FCS (or BSA) 
b. Incubate at room temp. for 1 hour 
3) Antibody binding 
a. Add purified antibody to each well – add 50μl of 1μg/ml  
b. Incubate at room temp. for 30 min 
c. Wash wells 3 times with 1XPBS + 0.05% Tween 20 
4) Secondary Antibody 
a. Add 50μl secondary anti-mouse IgG, IgG1, IgG2A, IgG2B, IgG3, and 
Neg (can include IgM if expected other than IgG) conjugated antibodies 
(1:1000 Alkaline Phosphotase conjugated or 1:5000 HRP conjugated) 
b. Incubate for 10 min at room temp. 
c. Wash 6 times with 1XPBS + 0.05%Tween 20 
d. Add appropriate substrate 
i. Expect two positive wells (IgG and Isotype) 
 
Buffers 
1) 0.1 M Glycine-HCl, pH 2.7 
• 11.1 g Glycine-HCl 
• 800 ml dH2O 
• Adjust pH to 2.7 with HCl 
• Add dH2O to 1L 
•  
2) 1.0 M Tris, pH 8.0 
• 121.1 g Tris 
• 700 ml of ddH2O 
• Adjust pH to 8.0 with HCl 
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• Add ddH2O to 1L 
• Sterile Filter 
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 ISOLATION AND GROWTH OF PRIMARY SWINE APPENDIX B.
RESPIRATORY EPITHELIAL CELLS 
 
 
Isolation of primary swine respiratory epithelial cells 
1) Place trachea on sterile 4X4 gauze on Petri dish lid 
2) Trim excess tissue from trachea and cut off ends 
3) Wash 2-3X in cold PBS 
4) Place tissue in 50 ml conical with Pronase/DNAsolution 
5) Incubate 48-72 hrs at 4O 
 
2-3 days later 
 
1) Add 4ml sterile filtered FCS (final concentration 10%) 
2) Invert tube several times 
3) Remove cell suspension with a pipet and place into new 50ml conical 
4) Rinse trachea and tube with 44 ml DMEM/F12, place extra cells in new 50 ml 
conical 
5) Spin tubes for 10 min at 1200 RPM at 4OC 
6) Remove supernatant, resuspend and combine cells from both 50ml conicals in 10 
ml of complete media (see complete RE media),  
7) Place in a petri dish and incubate 2hrs in 37O incubator (fibroblasts adhere, 
epithelial cells do not) 
8) Transfer supernatant into a new petri dish and incubate 2hrs in 37O incubator 
9) Transfer supernatant into a 50ml conical tube 
10) Wash petri dish with DMEM/F12 and add to conical tube 
11) Spin tube for 10 min at 1200 RPM at 4O 
12) Resuspend cells in 10 ml DMEM/F12 
13) Count cells 
14) Spin tube for 10 min at 1200 RPM at 4O 
15) Resuspend cells in BEGM  at a concentration of 1 X 106 cells / ml 
16) Place 1 ml in a collagen coated T75 and add 10 ml BEGM 
Freeze the remaining cells with 1 ml (1 X 106 cells) per vial 
 
 
Buffers 
1) Ca+ and Mg+ free MEM 
 (makes 1L) 
 0.4 g [5.36 mM] KCl 
 6.4 g [0.1 M] NaCl 
 3.7 g [44 mM] NaHCO3 
 0.125 g [0.9 mM] NaH2PO4 ∙ H2O 
 0.1 mg [0.25 µM] Fe(NO3)3 ∙ 9H2O (Dissolve 10 mg in 10 ml H2O and use 100µl 
 of this) 
 4.5 g [25 mM] D-glucose 
 0.015g [40µM] Phenol Red 
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 0.110 g [1mM] Sodium pyruvate 
 
 Add 950 ml Sterile H2O 
 pH balance to 7.5 
 add 10 ml pen/strep and fill to 1L 
 Filter using 0.2µm filter 
 Store at 4O C 
 
 
 2)  Pronase/DNAsolution 
 56 mg Pronase (Roche #165921) 
 4 mg DNase (sigma DN-25) 
 40 ml Ca+ and Mg+ free MEM (see Ca and Mg free MEM) 
 400 µl pen/strep (sigma P-0781) 
 
 Mix with stir bar until powder is dissolved 
 Sterile filter with 0.2µm Filter 
 Keep on ice 
 Put 2-3 50ml conical tubes with 40 ml of sterile PBS 
 
 
 3) Complete Respiratory Epithelial (RE) Media 
 2.5 ml FCS  
 0.5 mL MEM non essential amino acids (sigma M-7145) 
 60 µl insulin (UWHC 8917700) 
 47 ml DMEM/F12 with p/s (5ml/500ml bottle) 
 Store at 4OC 
 
 
Growth and propagation of pSRECs 
 
Making collagen 
1. In a beaker, add 10mg human placental collagen (type VI, Sigma C7521) to 20ml 
sterile H2O 
2. Add 40ul glacial acetic acid to the beaker (this helps to dissolve the collagen) 
3. Add a stirbar, stir at room temp until collagen is dissolved (30-60 min or so) 
4. Dilute collagen 1:10 (ie, add the 20ml mixture to 180ml sterile H2O) 
5. Sterile-filter through a 0.2um filter (may take 30-60 min or more) 
6. Store at 4C, use for collagen-coating plastic.  Can be stored for up to 4 months at 
4C. 
 
 
Coating plastic with collagen 
1.  Add collagen to tissue culture flasks/plates, leave overnight at room temp to  
 adhere (or leave for at least 6hr in 37C incubator, for collagen to adhere) 
Amount of collagen to add:  6ml per T75 flask 
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             ~500ul per well of 12-well plate 
                                              ~330ul per well of 24-well plate 
 
2. After collagen has adhered, prep collagen: 
 -aspirate off the water, leave flasks/plates uncovered in tissue culture hood    
        until the plastic dries completely (ie, until no liquid is visible on the plastic;  
      usually takes ~30 min for T75 flasks, ~15 min for plates) 
 -wash plastic 2X w/ PBS (6ml per T75, 500ul per 12-well, 330ul per 24-well) 
 -add media (Bronchial Epithelial Growth Medium [BEGM] from Lonza), put in  
      incubator until use.   
 
 
Reviving SRECs from LN2 
1. Pre-warm 10ml DMEM/F12 (we use Invitrogen’s) and 10ml BEGM 
2. Quick-thaw cells in 37C water bath 
3. Transfer cells to a 50ml conical tube, very slowly add pre-warmed DMEM/F12 
4. Spin for 10min at 1000rpm 
5. Resuspend cells in 10ml BEGM, add to the collagen-coated flask 
6. Change half of the media after a day or two; cells should be ready to split/plate in 
2-3 days 
 
 
Splitting/plating SRECs 
Day 1: collagen coat T75 flasks/12-well plates 
Day 2:  
1.   Take cells out of incubator, aspirate off BEGM 
2.   Add 4ml trypsin to each T75 flask, return to incubator for 5-6 min (during this  
       time, make 6ml of DMEM/F-12 + 10% FBS) 
3.   After trypsinization, stop with DMEM/F-12 + 10% FBS, put cells into 50mL  
 conical tubes 
4.   Spin cells for 10min at 1,000rpm  
5.   Remove supernatant, resuspend cells in exactly 10mL of plain DMEM/F-12 
6.   Take out 10ul of cells to count by hemocytometer 
7.   Spin cells for 10min at 1,000rpm (while spinning, count cells) 
8.   Take off supernatant, resuspend in BEGM for ~200,000cells/ml 
9.  Add cells to flasks and plates 
  1.5ml (~300,000 cells) to each T75 flask 
  0.5ml (~100,000 cells) to each well of 12-well plate 
  0.25ul (~50,000 cells) to each well of 24-well plate 
Day 3 
6) Change media.   
 
 
Typical cycle for using SRECs 
Day 1: collagen-coat 1 T75 flask 
Day 2: thaw one vial of passage 1 (P1) cells, plate in one T75 
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Day 3: media change, collagen-coat 3 T75 
Day 4: expand cells, from 1 T75 to 3 T75 (cells are now at passage 2) 
Day 5: media change, collagen-coat 1 T75 and 4-6 12-well plates 
Day 6: split/plate cells, into T75 (for continuing cell growth) and 12-well plates (for  
 experiments (cells now at passage 3) 
Day 7: media change, collagen-coat 3 T75 
Day 8: do the experiments on cells in 12-well plates, expand T75 cells from 1 into 3 T75  
          (these cells are now at passage 4) 
Day 9: media change, collagen-coat 4-6 12-well plates 
Day 10: plate cells in 12-well plates for experiments (cells now at passage 5) 
Day 11: media change 
Day 12: do experiments on passage 5 cells 
 
 
Notes 
-We have also used Lonza’s Small Airway Epithelial Growth Medium (SAGM), but 
we use BEGM most of the time 
 
-When drying collagen, ensure that all of the liquid is gone; the cells don’t like 
residual acetic acid 
 
-typical 37C, 5% CO2 incubator throughout 
 
-we have typically only used cells up to passage 5 for infectivity/replication 
experiments, because we do not want them to differentiate (and it has been shown by 
others that after passage 5 cells may differentiate), but cells remain viable past this 
point. 
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